Keywords
Last Name
Institution

Jean-Frederic Colombel

TitleSENIOR FACULTY
InstitutionMount Sinai
DepartmentGastroenterology
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Torres J, Danese S, Colombel JF. New therapeutic avenues in ulcerative colitis: thinking out of the box. Gut. 2013 Nov; 62(11):1642-52.
      View in: PubMed
    2. Bertin B, Dubuquoy L, Colombel JF, Desreumaux P. PPAR-Gamma in Ulcerative Colitis: A Novel Target for Intervention. Curr Drug Targets. 2013 Nov; 14(12):1501-7.
      View in: PubMed
    3. Gensollen T, Bourges C, Rihet P, Rostan A, Millet V, Noguchi T, Bourdon V, Sobol H, Dubuquoy L, Bertin B, Fumery M, Desreumaux P, Colombel JF, Hebuterne X, Hofman P, Naquet P, Galland F. Functional polymorphisms in the regulatory regions of the VNN1 gene are associated with susceptibility to inflammatory bowel diseases. Inflamm Bowel Dis. 2013 Oct; 19(11):2315-25.
      View in: PubMed
    4. Panaccione R, Colombel JF, Sandborn WJ, D'Haens G, Zhou Q, Pollack PF, Thakkar RB, Robinson AM. Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE. Aliment Pharmacol Ther. 2013 Nov; 38(10):1236-47.
      View in: PubMed
    5. Tavernier N, Fumery M, Peyrin-Biroulet L, Colombel JF, Gower-Rousseau C. Systematic review: fertility in non-surgically treated inflammatory bowel disease. Aliment Pharmacol Ther. 2013 Oct; 38(8):847-53.
      View in: PubMed
    6. Rahier JF, Dubuquoy L, Colombel JF, Jouret-Mourin A, Delos M, Ferrante M, Sokol H, Hertogh GD, Salleron J, Geboes K, Desreumaux P. Decreased lymphatic vessel density is associated with postoperative endoscopic recurrence in Crohn's disease. Inflamm Bowel Dis. 2013 Sep; 19(10):2084-90.
      View in: PubMed
    7. Peyrin-Biroulet L, Reinisch W, Colombel JF, Mantzaris GJ, Kornbluth A, Diamond R, Rutgeerts P, Tang LK, Cornillie FJ, Sandborn WJ. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial. Gut. 2014 Jan; 63(1):88-95.
      View in: PubMed
    8. Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A. Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med. 2013 Aug 22; 369(8):711-21.
      View in: PubMed
    9. Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, Van Assche G, Axler J, Kim HJ, Danese S, Fox I, Milch C, Sankoh S, Wyant T, Xu J, Parikh A. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013 Aug 22; 369(8):699-710.
      View in: PubMed
    10. Söderman J, Norén E, Christiansson M, Bragde H, Thiébaut R, Hugot JP, Tysk C, O'Morain CA, Gassull M, Finkel Y, Colombel JF, Lémann M, Almer S. Analysis of single nucleotide polymorphisms in the region of CLDN2-MORC4 in relation to inflammatory bowel disease. World J Gastroenterol. 2013 Aug 14; 19(30):4935-43.
      View in: PubMed
    11. Ferrante M, Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens GR, van der Woude CJ, Danese S, Diamond RH, Oortwijn AF, Tang KL, Miller M, Cornillie F, Rutgeerts PJ. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC. Gastroenterology. 2013 Nov; 145(5):978-986.e5.
      View in: PubMed
    12. Peneau A, Savoye G, Turck D, Dauchet L, Fumery M, Salleron J, Lerebours E, Ligier K, Vasseur F, Dupas JL, Mouterde O, Spyckerelle C, Djeddi D, Peyrin-Biroulet L, Colombel JF, Gower-Rousseau C. Mortality and cancer in pediatric-onset inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2013 Oct; 108(10):1647-53.
      View in: PubMed
    13. Bernheim O, Colombel JF, Ullman TA, Laharie D, Beaugerie L, Itzkowitz SH. The management of immunosuppression in patients with inflammatory bowel disease and cancer. Gut. 2013 Nov; 62(11):1523-8.
      View in: PubMed
    14. Travis SP, Schnell D, Krzeski P, Abreu MT, Altman DG, Colombel JF, Feagan BG, Hanauer SB, Lichtenstein GR, Marteau PR, Reinisch W, Sands BE, Yacyshyn BR, Schnell P, Bernhardt CA, Mary JY, Sandborn WJ. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology. 2013 Nov; 145(5):987-95.
      View in: PubMed
    15. Rousseaux C, El-Jamal N, Fumery M, Dubuquoy C, Romano O, Chatelain D, Langlois A, Bertin B, Buob D, Colombel JF, Cortot A, Desreumaux P, Dubuquoy L. The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPAR?. Carcinogenesis. 2013 Nov; 34(11):2580-6.
      View in: PubMed
    16. Panaccione R, Colombel JF, Louis E, Peyrin-Biroulet L, Sandborn WJ. Evolving definitions of remission in Crohn's disease. Inflamm Bowel Dis. 2013 Jul; 19(8):1645-53.
      View in: PubMed
    17. Sandborn WJ, Feagan BG, Marano C, Zhang H, Strauss R, Johanns J, Adedokun OJ, Guzzo C, Colombel JF, Reinisch W, Gibson PR, Collins J, Järnerot G, Rutgeerts P. Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis. Gastroenterology. 2014 Jan; 146(1):96-109.e1.
      View in: PubMed
    18. Sandborn WJ, Feagan BG, Marano C, Zhang H, Strauss R, Johanns J, Adedokun OJ, Guzzo C, Colombel JF, Reinisch W, Gibson PR, Collins J, Järnerot G, Hibi T, Rutgeerts P. Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis. Gastroenterology. 2014 Jan; 146(1):85-95.
      View in: PubMed
    19. Colombel JF. Measuring Disability in IBD: The IBD Disability Index. Gastroenterol Hepatol (N Y). 2013 May; 9(5):300-2.
      View in: PubMed
    20. Papay P, Ignjatovic A, Karmiris K, Amarante H, Milheller P, Feagan B, D'Haens G, Marteau P, Reinisch W, Sturm A, Steinwurz F, Egan L, Panés J, Louis E, Colombel JF, Panaccione R. Optimising monitoring in the management of Crohn's disease: a physician's perspective. J Crohns Colitis. 2013 Sep 1; 7(8):653-69.
      View in: PubMed
    21. Torres J, Buche S, Delaporte E, Colombel JF. Skin side effects of inflammatory bowel disease therapy. Inflamm Bowel Dis. 2013 Apr; 19(5):1086-98.
      View in: PubMed
    22. Billioud V, Ford AC, Tedesco ED, Colombel JF, Roblin X, Peyrin-Biroulet L. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis. J Crohns Colitis. 2013 Dec 1; 7(11):853-67.
      View in: PubMed
    23. Vasseur F, Sendid B, Broly F, Gower-Rousseau C, Sarazin A, Standaert-Vitse A, Colombel JF, Poulain D, Jouault T. The CARD8 p.C10X mutation associates with a low anti-glycans antibody response in patients with Crohn's disease. BMC Med Genet. 2013; 14:35.
      View in: PubMed
    24. Sandborn WJ, Colombel JF, Panés J, Castillo M, Robinson AM, Zhou Q, Yang M, Thakkar R. Exploring the use of adalimumab for patients with moderate Crohn's disease: Subanalyses from induction and maintenance trials. J Crohns Colitis. 2013 Dec 15; 7(12):958-67.
      View in: PubMed
    25. Sandborn WJ, Colombel JF, D'Haens G, Plevy SE, Panés J, Robinson AM, Pollack PF, Zhou Q, Castillo M, Thakkar RB. Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn's disease. Curr Med Res Opin. 2013 May; 29(5):483-93.
      View in: PubMed
    26. Danese S, Colombel JF, Peyrin-Biroulet L, Rutgeerts P, Reinisch W. Review article: the role of anti-TNF in the management of ulcerative colitis -- past, present and future. Aliment Pharmacol Ther. 2013 May; 37(9):855-66.
      View in: PubMed
    27. Landman C, Nahon S, Cosnes J, Bouhnik Y, Brixi-Benmansour H, Bouguen G, Colombel JF, Savoye G, Coffin B, Abitbol V, Filippi J, Laharie D, Moreau J, Veyrac M, Allez M, Marteau P. Portomesenteric vein thrombosis in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Mar; 19(3):582-9.
      View in: PubMed
    28. Melmed GY, Siegel CA, Spiegel BM, Allen JI, Cima R, Colombel JF, Dassopoulos T, Denson LA, Dudley-Brown S, Garb A, Hanauer SB, Kappelman MD, Lewis JD, Lynch I, Moynihan A, Rubin DT, Sartor RB, Schwartz RM, Wolf DC, Ullman TA. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis. 2013 Mar; 19(3):662-8.
      View in: PubMed
    29. Van Assche G, Herrmann KA, Louis E, Everett SM, Colombel JF, Rahier JF, Vanbeckevoort D, Meunier P, Tolan D, Ernst O, Rutgeerts P, Vermeire S, Aerden I, Oortwijn A, Ochsenkühn T. Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease. J Crohns Colitis. 2013 Dec 15; 7(12):950-7.
      View in: PubMed
    30. Torres J, Bao X, Iuga AC, Chen A, Harpaz N, Ullman T, Cohen BL, Pineton de Chambrun G, Asciutti S, Odin JA, Sachar DB, Gaskins HR, Setchell K, Colombel JF, Itzkowitz SH. Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia. Inflamm Bowel Dis. 2013 Feb; 19(2):275-82.
      View in: PubMed
    31. Dreux N, Denizot J, Martinez-Medina M, Mellmann A, Billig M, Kisiela D, Chattopadhyay S, Sokurenko E, Neut C, Gower-Rousseau C, Colombel JF, Bonnet R, Darfeuille-Michaud A, Barnich N. Point mutations in FimH adhesin of Crohn's disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response. PLoS Pathog. 2013 Jan; 9(1):e1003141.
      View in: PubMed
    32. Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV, Tysk C, O'Morain C, Moum B, Colombel JF. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013 Apr; 62(4):630-49.
      View in: PubMed
    33. Svrcek M, El-Murr N, Wanherdrick K, Dumont S, Beaugerie L, Cosnes J, Colombel JF, Tiret E, Fléjou JF, Lesuffleur T, Duval A. Overexpression of microRNAs-155 and 21 targeting mismatch repair proteins in inflammatory bowel diseases. Carcinogenesis. 2013 Apr; 34(4):828-34.
      View in: PubMed
    34. Colombel JF, Louis E, Peyrin-Biroulet L, Sandborn WJ, Panaccione R. Deep remission: a new concept? Dig Dis. 2012; 30 Suppl 3:107-11.
      View in: PubMed
    35. Boualit M, Salleron J, Turck D, Fumery M, Savoye G, Dupas JL, Lerebours E, Duhamel A, Merle V, Cortot A, Colombel JF, Peyrin-Biroulet L, Gower-Rousseau C. Long-term outcome after first intestinal resection in pediatric-onset Crohn's disease: a population-based study. Inflamm Bowel Dis. 2013 Jan; 19(1):7-14.
      View in: PubMed
    36. Jung C, Colombel JF, Lemann M, Beaugerie L, Allez M, Cosnes J, Vernier-Massouille G, Gornet JM, Gendre JP, Cezard JP, Ruemmele FM, Turck D, Merlin F, Zouali H, Libersa C, Dieudé P, Soufir N, Thomas G, Hugot JP. Genotype/phenotype analyses for 53 Crohn's disease associated genetic polymorphisms. PLoS One. 2012; 7(12):e52223.
      View in: PubMed
    37. Allen PB, Kamm MA, Peyrin-Biroulet L, Studd C, McDowell C, Allen BC, Connell WR, De Cruz PP, Bell SJ, Elliot RP, Brown S, Desmond PV, Lemann M, Colombel JF. Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013 Feb; 37(4):438-44.
      View in: PubMed
    38. Dussault C, Gower-Rousseau C, Salleron J, Vernier-Massouille G, Branche J, Colombel JF, Maunoury V. Small bowel capsule endoscopy for management of Crohn's disease: a retrospective tertiary care centre experience. Dig Liver Dis. 2013 Jul; 45(7):558-61.
      View in: PubMed
    39. Peyrin-Biroulet L, Billioud V, D'Haens G, Panaccione R, Feagan B, Panés J, Danese S, Schreiber S, Ogata H, Hibi T, Higgins PD, Beaugerie L, Chowers Y, Louis E, Steinwurz F, Reinisch W, Rutgeerts P, Colombel JF, Travis S, Sandborn WJ. Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process. Am J Gastroenterol. 2012 Dec; 107(12):1770-6.
      View in: PubMed
    40. Sandborn WJ, Colombel JF, D'Haens G, Van Assche G, Wolf D, Kron M, Lazar A, Robinson AM, Yang M, Chao JD, Thakkar R. One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2. Aliment Pharmacol Ther. 2013 Jan; 37(2):204-13.
      View in: PubMed
    41. Gower-Rousseau C, Vasseur F, Fumery M, Savoye G, Salleron J, Dauchet L, Turck D, Cortot A, Peyrin-Biroulet L, Colombel JF. Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Dig Liver Dis. 2013 Feb; 45(2):89-94.
      View in: PubMed
    42. Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Nachury M, Moreau J, Delchier JC, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Dupas JL, Carbonnel F, Bommelaer G, Coffin B, Roblin X, Van Assche G, Esteve M, Färkkilä M, Gisbert JP, Marteau P, Nahon S, de Vos M, Franchimont D, Mary JY, Colombel JF, Lémann M. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet. 2012 Dec 1; 380(9857):1909-15.
      View in: PubMed
    43. Dignass A, Lindsay JO, Sturm A, Windsor A, Colombel JF, Allez M, D'Haens G, D'Hoore A, Mantzaris G, Novacek G, Oresland T, Reinisch W, Sans M, Stange E, Vermeire S, Travis S, Van Assche G. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis. 2012 Dec; 6(10):991-1030.
      View in: PubMed
    44. Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S, Travis S, Lindsay JO, Van Assche G. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012 Dec; 6(10):965-90.
      View in: PubMed
    45. Seminerio JL, Loftus EV, Colombel JF, Thapa P, Sandborn WJ. Infliximab for Crohn's disease: the first 500 patients followed up through 2009. Dig Dis Sci. 2013 Mar; 58(3):797-806.
      View in: PubMed
    46. Branche J, Attar A, Vernier-Massouille G, Bulois P, Colombel JF, Bouhnik Y, Maunoury V. Extractible self-expandable metal stent in the treatment of Crohn's disease anastomotic strictures. Endoscopy. 2012; 44 Suppl 2 UCTN:E325-6.
      View in: PubMed
    47. D'Haens G, Feagan B, Colombel JF, Sandborn WJ, Reinisch W, Rutgeerts P, Carbonnel F, Mary JY, Danese S, Fedorak RN, Hanauer S, Lémann M. Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease. Gastroenterology. 2012 Dec; 143(6):1461-9.
      View in: PubMed
    48. Desreumaux P, Foussat A, Allez M, Beaugerie L, Hébuterne X, Bouhnik Y, Nachury M, Brun V, Bastian H, Belmonte N, Ticchioni M, Duchange A, Morel-Mandrino P, Neveu V, Clerget-Chossat N, Forte M, Colombel JF. Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. Gastroenterology. 2012 Nov; 143(5):1207-17.e1-2.
      View in: PubMed
    49. Ruemmele FM, Colombel JF. Commentaries on "Workshop report: developing a pediatric inflammatory bowel diseases network and data platform in Canada": networking in pediatric inflammatory bowel disease: the French GETAID Pédiatrique experience. J Pediatr Gastroenterol Nutr. 2012 Aug; 55(2):123.
      View in: PubMed
    50. Pineton de Chambrun GP, Torres J, Darfeuille-Michaud A, Colombel JF. The role of anti(myco)bacterial interventions in the management of IBD: is there evidence at all? Dig Dis. 2012; 30(4):358-67.
      View in: PubMed
    51. Cohen BL, Torres J, Colombel JF. Immunosuppression in inflammatory bowel disease: how much is too much? Curr Opin Gastroenterol. 2012 Jul; 28(4):341-8.
      View in: PubMed
    52. Schreiber S, Reinisch W, Colombel JF, Sandborn WJ, Hommes DW, Robinson AM, Huang B, Lomax KG, Pollack PF. Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease. J Crohns Colitis. 2013 Apr 1; 7(3):213-21.
      View in: PubMed
    53. Lichtenstein GR, Rutgeerts P, Sandborn WJ, Sands BE, Diamond RH, Blank M, Montello J, Tang L, Cornillie F, Colombel JF. A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease. Am J Gastroenterol. 2012 Jul; 107(7):1051-63.
      View in: PubMed
    54. Hébuterne X, Lémann M, Bouhnik Y, Dewit O, Dupas JL, Mross M, D'Haens G, Mitchev K, Ernault É, Vermeire S, Brixi-Benmansour H, Moreels TG, Mary JY, Marteau P, Colombel JF. Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol. Gut. 2013 Feb; 62(2):201-8.
      View in: PubMed
    55. Sandborn WJ, Colombel JF, Sands BE, Rutgeerts P, Targan SR, Panaccione R, Bressler B, Geboes K, Schreiber S, Aranda R, Gujrathi S, Luo A, Peng Y, Salter-Cid L, Hanauer SB. Abatacept for Crohn's disease and ulcerative colitis. Gastroenterology. 2012 Jul; 143(1):62-69.e4.
      View in: PubMed
    56. Colombel JF. When should combination therapy for patients with Crohn's disease be discontinued? Gastroenterol Hepatol (N Y). 2012 Apr; 8(4):259-62.
      View in: PubMed
    57. Rutgeerts P, Van Assche G, Sandborn WJ, Wolf DC, Geboes K, Colombel JF, Reinisch W. Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial. Gastroenterology. 2012 May; 142(5):1102-1111.e2.
      View in: PubMed
    58. Hommes D, Colombel JF, Emery P, Greco M, Sandborn WJ. Changing Crohn's disease management: need for new goals and indices to prevent disability and improve quality of life. J Crohns Colitis. 2012 Feb; 6 Suppl 2:S224-34.
      View in: PubMed
    59. Nahon S, Lahmek P, Durance C, Olympie A, Lesgourgues B, Colombel JF, Gendre JP. Risk factors of anxiety and depression in inflammatory bowel disease. Inflamm Bowel Dis. 2012 Nov; 18(11):2086-91.
      View in: PubMed
    60. Savoye G, Salleron J, Gower-Rousseau C, Dupas JL, Vernier-Massouille G, Fumery M, Merle V, Lerebours E, Cortot A, Turck D, Salomez JL, Lemann M, Colombel JF, Duhamel A. Clinical predictors at diagnosis of disabling pediatric Crohn's disease. Inflamm Bowel Dis. 2012 Nov; 18(11):2072-8.
      View in: PubMed
    61. Attar A, Maunoury V, Vahedi K, Vernier-Massouille G, Vida S, Bulois P, Colombel JF, Bouhnik Y. Safety and efficacy of extractible self-expandable metal stents in the treatment of Crohn's disease intestinal strictures: a prospective pilot study. Inflamm Bowel Dis. 2012 Oct; 18(10):1849-54.
      View in: PubMed
    62. Torres J, Billioud V, Sachar DB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis as a progressive disease: the forgotten evidence. Inflamm Bowel Dis. 2012 Jul; 18(7):1356-63.
      View in: PubMed
    63. Achleitner U, Coenen M, Colombel JF, Peyrin-Biroulet L, Sahakyan N, Cieza A. Identification of areas of functioning and disability addressed in inflammatory bowel disease-specific patient reported outcome measures. J Crohns Colitis. 2012 Jun; 6(5):507-17.
      View in: PubMed
    64. Sandborn WJ, van Assche G, Reinisch W, Colombel JF, D'Haens G, Wolf DC, Kron M, Tighe MB, Lazar A, Thakkar RB. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2012 Feb; 142(2):257-65.e1-3.
      View in: PubMed
    65. Colombel JF, Feagan BG, Sandborn WJ, Van Assche G, Robinson AM. Therapeutic drug monitoring of biologics for inflammatory bowel disease. Inflamm Bowel Dis. 2012 Feb; 18(2):349-58.
      View in: PubMed
    66. Ferrante M, Karmiris K, Newnham E, Siffledeen J, Zelinkova Z, van Assche G, Lakatos PL, Panés J, Sturm A, Travis S, van der Woude CJ, Reinisch W, Colombel JF, Panaccione R. Physician perspectives on unresolved issues in the use of conventional therapy in Crohn's disease: results from an international survey and discussion programme. J Crohns Colitis. 2012 Feb; 6(1):116-31.
      View in: PubMed
    67. Travis SP, Schnell D, Krzeski P, Abreu MT, Altman DG, Colombel JF, Feagan BG, Hanauer SB, Lémann M, Lichtenstein GR, Marteau PR, Reinisch W, Sands BE, Yacyshyn BR, Bernhardt CA, Mary JY, Sandborn WJ. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut. 2012 Apr; 61(4):535-42.
      View in: PubMed
    68. Louis E, Mary JY, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Dupas JL, Pillant H, Picon L, Veyrac M, Flamant M, Savoye G, Jian R, Devos M, Porcher R, Paintaud G, Piver E, Colombel JF, Lemann M. Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped. Gastroenterology. 2012 Jan; 142(1):63-70.e5; quiz e31.
      View in: PubMed
    69. Peyrin-Biroulet L, Gonzalez F, Dubuquoy L, Rousseaux C, Dubuquoy C, Decourcelle C, Saudemont A, Tachon M, Béclin E, Odou MF, Neut C, Colombel JF, Desreumaux P. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease. Gut. 2012 Jan; 61(1):78-85.
      View in: PubMed
    70. Pariente B, Pineton de Chambrun G, Krzysiek R, Desroches M, Louis G, De Cassan C, Baudry C, Gornet JM, Desreumaux P, Emilie D, Colombel JF, Allez M. Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2012 Jul; 18(7):1199-206.
      View in: PubMed
    71. Van Assche G, Lewis JD, Lichtenstein GR, Loftus EV, Ouyang Q, Panes J, Siegel CA, Sandborn WJ, Travis SP, Colombel JF. The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety. Am J Gastroenterol. 2011 Sep; 106(9):1594-602; quiz 1593, 1603.
      View in: PubMed
    72. Pineton de Chambrun G, Gonzalez F, Canva JY, Gonzalez S, Houssin L, Desreumaux P, Cortot A, Colombel JF. Natural history of eosinophilic gastroenteritis. Clin Gastroenterol Hepatol. 2011 Nov; 9(11):950-956.e1.
      View in: PubMed
    73. Torres J, Billioud V, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis as a sole mucosal disease: another misunderstanding? Gut. 2012 Apr; 61(4):633.
      View in: PubMed
    74. Rahier JF, De Beauce S, Dubuquoy L, Erdual E, Colombel JF, Jouret-Mourin A, Geboes K, Desreumaux P. Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease. Aliment Pharmacol Ther. 2011 Sep; 34(5):533-43.
      View in: PubMed
    75. Roblin X, Neut C, Darfeuille-Michaud A, Colombel JF. Local appendiceal dysbiosis: the missing link between the appendix and ulcerative colitis? Gut. 2012 Apr; 61(4):635-6.
      View in: PubMed
    76. Pariente B, Peyrin-Biroulet L, Cohen L, Zagdanski AM, Colombel JF. Gastroenterology review and perspective: the role of cross-sectional imaging in evaluating bowel damage in Crohn disease. AJR Am J Roentgenol. 2011 Jul; 197(1):42-9.
      View in: PubMed
    77. Colombel JF, Rutgeerts P, Reinisch W, Esser D, Wang Y, Lang Y, Marano CW, Strauss R, Oddens BJ, Feagan BG, Hanauer SB, Lichtenstein GR, Present D, Sands BE, Sandborn WJ. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology. 2011 Oct; 141(4):1194-201.
      View in: PubMed
    78. Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas JL, Godeberge P, Hugot JP, Lémann M, Nahon S, Sabaté JM, Tucat G, Beaugerie L. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology. 2011 Nov; 141(5):1621-28.e1-5.
      View in: PubMed
    79. Torres J, Pineton de Chambrun G, Itzkowitz S, Sachar DB, Colombel JF. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. Aliment Pharmacol Ther. 2011 Sep; 34(5):497-508.
      View in: PubMed
    80. Peyrin-Biroulet L, Cieza A, Sandborn WJ, Coenen M, Chowers Y, Hibi T, Kostanjsek N, Stucki G, Colombel JF. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut. 2012 Feb; 61(2):241-7.
      View in: PubMed
    81. Kamm MA, Hanauer SB, Panaccione R, Colombel JF, Sandborn WJ, Pollack PF, Zhou Q, Robinson AM. Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease. Aliment Pharmacol Ther. 2011 Aug; 34(3):306-17.
      View in: PubMed
    82. Bourgine J, Garat A, Allorge D, Crunelle-Thibaut A, Lo-Guidice JM, Colombel JF, Broly F, Billaut-Laden I. Evidence for a functional genetic polymorphism of the Rho-GTPase Rac1. Implication in azathioprine response? Pharmacogenet Genomics. 2011 Jun; 21(6):313-24.
      View in: PubMed
    83. Tremblay L, Pineton de Chambrun G, De Vroey B, Lavogiez C, Delaporte E, Colombel JF, Cortot A. Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases. J Crohns Colitis. 2011 Oct; 5(5):457-60.
      View in: PubMed
    84. Maunoury V, Vernier-Massouille G, Colombel JF. Value in capsule retention in Crohn's disease. Inflamm Bowel Dis. 2011 Aug; 17(8):E84-5.
      View in: PubMed
    85. Reinisch W, Sandborn WJ, Rutgeerts P, Feagan BG, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Blank M, Lang Y, Johanns J, Colombel JF, Present D, Sands BE. Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies. Inflamm Bowel Dis. 2012 Feb; 18(2):201-11.
      View in: PubMed
    86. Thiébaut R, Douchin V, Jung C, Merlin F, Colombel JF, Lemann M, Almer S, Tysk C, O'Morain C, Gassull M, Finkel Y, Zouali H, Pascoe L, Hugot JP. RIP2 polymorphisms in inflammatory bowel diseases. Inflamm Bowel Dis. 2011 Apr; 17(4):1055.
      View in: PubMed
    87. Chouraki V, Savoye G, Dauchet L, Vernier-Massouille G, Dupas JL, Merle V, Laberenne JE, Salomez JL, Lerebours E, Turck D, Cortot A, Gower-Rousseau C, Colombel JF. The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther. 2011 May; 33(10):1133-42.
      View in: PubMed
    88. Leblanc S, Allez M, Seksik P, Flourié B, Peeters H, Dupas JL, Bouguen G, Peyrin-Biroulet L, Duclos B, Bourreille A, Dewit O, Bouhnik Y, Michetti P, Chaussade S, Saussure P, Mary JY, Colombel JF, Lémann M. Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. Am J Gastroenterol. 2011 Apr; 106(4):771-7.
      View in: PubMed
    89. Sura R, Colombel JF, Van Kruiningen HJ. Lymphatics, tertiary lymphoid organs and the granulomas of Crohn's disease: an immunohistochemical study. Aliment Pharmacol Ther. 2011 Apr; 33(8):930-9.
      View in: PubMed
    90. Danese S, Colombel JF, Reinisch W, Rutgeerts PJ. Review article: infliximab for Crohn's disease treatment--shifting therapeutic strategies after 10 years of clinical experience. Aliment Pharmacol Ther. 2011 Apr; 33(8):857-69.
      View in: PubMed
    91. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, Lagacé C, Scott R, Amininejad L, Bumpstead S, Baidoo L, Baldassano RN, Barclay M, Bayless TM, Brand S, Büning C, Colombel JF, Denson LA, De Vos M, Dubinsky M, Edwards C, Ellinghaus D, Fehrmann RS, Floyd JA, Florin T, Franchimont D, Franke L, Georges M, Glas J, Glazer NL, Guthery SL, Haritunians T, Hayward NK, Hugot JP, Jobin G, Laukens D, Lawrance I, Lémann M, Levine A, Libioulle C, Louis E, McGovern DP, Milla M, Montgomery GW, Morley KI, Mowat C, Ng A, Newman W, Ophoff RA, Papi L, Palmieri O, Peyrin-Biroulet L, Panés J, Phillips A, Prescott NJ, Proctor DD, Roberts R, Russell R, Rutgeerts P, Sanderson J, Sans M, Schumm P, Seibold F, Sharma Y, Simms LA, Seielstad M, Steinhart AH, Targan SR, van den Berg LH, Vatn M, Verspaget H, Walters T, Wijmenga C, Wilson DC, Westra HJ, Xavier RJ, Zhao ZZ, Ponsioen CY, Andersen V, Torkvist L, Gazouli M, Anagnou NP, Karlsen TH, Kupcinskas L, Sventoraityte J, Mansfield JC, Kugathasan S, Silverberg MS, Halfvarson J, Rotter JI, Mathew CG, Griffiths AM, Gearry R, Ahmad T, Brant SR, Chamaillard M, Satsangi J, Cho JH, Schreiber S, Daly MJ, Barrett JC, Parkes M, Annese V, Hakonarson H, Radford-Smith G, Duerr RH, Vermeire S, Weersma RK, Rioux JD. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet. 2011 Mar; 43(3):246-52.
      View in: PubMed
    92. Crombé V, Salleron J, Savoye G, Dupas JL, Vernier-Massouille G, Lerebours E, Cortot A, Merle V, Vasseur F, Turck D, Gower-Rousseau C, Lémann M, Colombel JF, Duhamel A. Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: a population-based study. Inflamm Bowel Dis. 2011 Oct; 17(10):2144-52.
      View in: PubMed
    93. Baumgart DC, Bernstein CN, Abbas Z, Colombel JF, Day AS, D'Haens G, Dotan I, Goh KL, Hibi T, Kozarek RA, Quigley EM, Reinisch W, Sands BE, Sollano JD, Steinhart AH, Steinwurz F, Vatn MH, Yamamoto-Furusho JK. IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meeting. Inflamm Bowel Dis. 2011 Feb; 17(2):639-44.
      View in: PubMed
    94. Seksik P, Mary JY, Beaugerie L, Lémann M, Colombel JF, Vernier-Massouille G, Cosnes J. Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine. Inflamm Bowel Dis. 2011 Feb; 17(2):565-72.
      View in: PubMed
    95. De Vroey B, Colombel JF. IBD in 2010: optimizing treatment and minimizing adverse events. Nat Rev Gastroenterol Hepatol. 2011 Feb; 8(2):74-6.
      View in: PubMed
    96. Sandborn WJ, Colombel JF, Schreiber S, Plevy SE, Pollack PF, Robinson AM, Chao J, Mulani P. Dosage adjustment during long-term adalimumab treatment for Crohn's disease: clinical efficacy and pharmacoeconomics. Inflamm Bowel Dis. 2011 Jan; 17(1):141-51.
      View in: PubMed
    97. Momozawa Y, Mni M, Nakamura K, Coppieters W, Almer S, Amininejad L, Cleynen I, Colombel JF, de Rijk P, Dewit O, Finkel Y, Gassull MA, Goossens D, Laukens D, Lémann M, Libioulle C, O'Morain C, Reenaers C, Rutgeerts P, Tysk C, Zelenika D, Lathrop M, Del-Favero J, Hugot JP, de Vos M, Franchimont D, Vermeire S, Louis E, Georges M. Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet. 2011 Jan; 43(1):43-7.
      View in: PubMed
    98. Coelho J, Beaugerie L, Colombel JF, Hébuterne X, Lerebours E, Lémann M, Baumer P, Cosnes J, Bourreille A, Gendre JP, Seksik P, Blain A, Metman EH, Nisard A, Cadiot G, Veyrac M, Coffin B, Dray X, Carrat F, Marteau P. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut. 2011 Feb; 60(2):198-203.
      View in: PubMed
    99. Pariente B, Cosnes J, Danese S, Sandborn WJ, Lewin M, Fletcher JG, Chowers Y, D'Haens G, Feagan BG, Hibi T, Hommes DW, Irvine EJ, Kamm MA, Loftus EV, Louis E, Michetti P, Munkholm P, Oresland T, Panés J, Peyrin-Biroulet L, Reinisch W, Sands BE, Schoelmerich J, Schreiber S, Tilg H, Travis S, van Assche G, Vecchi M, Mary JY, Colombel JF, Lémann M. Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis. 2011 Jun; 17(6):1415-22.
      View in: PubMed
    100. D'Haens GR, Panaccione R, Higgins PD, Vermeire S, Gassull M, Chowers Y, Hanauer SB, Herfarth H, Hommes DW, Kamm M, Löfberg R, Quary A, Sands B, Sood A, Watermeyer G, Watermayer G, Lashner B, Lémann M, Plevy S, Reinisch W, Schreiber S, Siegel C, Targan S, Watanabe M, Feagan B, Sandborn WJ, Colombel JF, Travis S. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? Am J Gastroenterol. 2011 Feb; 106(2):199-212; quiz 213.
      View in: PubMed
    101. Sandborn WJ, Colombel JF, Frankel M, Hommes D, Lowder JN, Mayer L, Plevy S, Stokkers P, Travis S, Van Assche G, Baumgart DC, Targan SR. Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis. Gut. 2010 Nov; 59(11):1485-92.
      View in: PubMed
    102. Baudet A, Colombel JF, Cortot A, Dupas JL, Brazier F, Savoye G, Lerebours E, Justum AM, Reimund JM. A fulminant colitis index greater or equal to 8 is not predictive of colectomy risk in infliximab-treated moderate-to-severe ulcerative colitis attacks. Gastroenterol Clin Biol. 2010 Nov; 34(11):612-7.
      View in: PubMed
    103. Rahier JF, Buche S, Peyrin-Biroulet L, Bouhnik Y, Duclos B, Louis E, Papay P, Allez M, Cosnes J, Cortot A, Laharie D, Reimund JM, Lémann M, Delaporte E, Colombel JF. Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy. Clin Gastroenterol Hepatol. 2010 Dec; 8(12):1048-55.
      View in: PubMed
    104. Peyrin-Biroulet L, Loftus EV, Colombel JF, Sandborn WJ. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts. Inflamm Bowel Dis. 2011 Jan; 17(1):471-8.
      View in: PubMed
    105. Colombel JF. Understanding combination therapy with biologics and immunosuppressives for the treatment of Crohn's disease. Gastroenterol Hepatol (N Y). 2010 Aug; 6(8):486-90.
      View in: PubMed
    106. Zerbib P, Koriche D, Truant S, Bouras AF, Vernier-Massouille G, Seguy D, Pruvot FR, Cortot A, Colombel JF. Pre-operative management is associated with low rate of post-operative morbidity in penetrating Crohn's disease. Aliment Pharmacol Ther. 2010 Aug; 32(3):459-65.
      View in: PubMed
    107. Hanauer SB, Panes J, Colombel JF, Bloomfield R, Schreiber S, Sandborn WJ. Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn's disease. Aliment Pharmacol Ther. 2010 Aug; 32(3):384-93.
      View in: PubMed
    108. Sandborn WJ, Abreu MT, D'Haens G, Colombel JF, Vermeire S, Mitchev K, Jamoul C, Fedorak RN, Spehlmann ME, Wolf DC, Lee S, Rutgeerts P. Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab. Clin Gastroenterol Hepatol. 2010 Aug; 8(8):688-695.e2.
      View in: PubMed
    109. Torres J, De Vroey B, Noël MP, Notteghem B, Colombel JF. Recurrent small bowel ischemia in a patient with paroxysmal nocturnal hemoglobinuria. Nat Rev Gastroenterol Hepatol. 2010 Jul; 7(7):410-4.
      View in: PubMed
    110. Declercq C, Gower-Rousseau C, Vernier-Massouille G, Salleron J, Baldé M, Poirier G, Lerebours E, Dupas JL, Merle V, Marti R, Duhamel A, Cortot A, Salomez JL, Colombel JF. Mapping of inflammatory bowel disease in northern France: spatial variations and relation to affluence. Inflamm Bowel Dis. 2010 May; 16(5):807-12.
      View in: PubMed
    111. Peyrin-Biroulet L, Beisner J, Wang G, Nuding S, Oommen ST, Kelly D, Parmentier-Decrucq E, Dessein R, Merour E, Chavatte P, Grandjean T, Bressenot A, Desreumaux P, Colombel JF, Desvergne B, Stange EF, Wehkamp J, Chamaillard M. Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci U S A. 2010 May 11; 107(19):8772-7.
      View in: PubMed
    112. Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens G, Diamond RH, Broussard DL, Tang KL, van der Woude CJ, Rutgeerts P. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010 Apr 15; 362(15):1383-95.
      View in: PubMed
    113. Sandborn WJ, Schreiber S, Hanauer SB, Colombel JF, Bloomfield R, Lichtenstein GR. Reinduction with certolizumab pegol in patients with relapsed Crohn's disease: results from the PRECiSE 4 Study. Clin Gastroenterol Hepatol. 2010 Aug; 8(8):696-702.e1.
      View in: PubMed
    114. Panaccione R, Colombel JF, Sandborn WJ, Rutgeerts P, D'Haens GR, Robinson AM, Chao J, Mulani PM, Pollack PF. Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease. Aliment Pharmacol Ther. 2010 Jun; 31(12):1296-309.
      View in: PubMed
    115. Schreiber S, Colombel JF, Bloomfield R, Nikolaus S, Schölmerich J, Panés J, Sandborn WJ. Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data. Am J Gastroenterol. 2010 Jul; 105(7):1574-82.
      View in: PubMed
    116. Travis SP, Spiller RC, Holzer P, Colombel JF. IBD and IBS: novel mechanisms and future practice. Preface. Dig Dis. 2009; 27 Suppl 1:1-2.
      View in: PubMed
    117. Poulain D, Sendid B, Standaert-Vitse A, Fradin C, Jouault T, Jawhara S, Colombel JF. Yeasts: neglected pathogens. Dig Dis. 2009; 27 Suppl 1:104-10.
      View in: PubMed
    118. Grimaud JC, Munoz-Bongrand N, Siproudhis L, Abramowitz L, Sénéjoux A, Vitton V, Gambiez L, Flourié B, Hébuterne X, Louis E, Coffin B, De Parades V, Savoye G, Soulé JC, Bouhnik Y, Colombel JF, Contou JF, François Y, Mary JY, Lémann M. Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease. Gastroenterology. 2010 Jun; 138(7):2275-81, 2281.e1.
      View in: PubMed
    119. Vasseur F, Gower-Rousseau C, Vernier-Massouille G, Dupas JL, Merle V, Merlin B, Lerebours E, Savoye G, Salomez JL, Cortot A, Colombel JF, Turck D. Nutritional status and growth in pediatric Crohn's disease: a population-based study. Am J Gastroenterol. 2010 Aug; 105(8):1893-900.
      View in: PubMed
    120. Peyrin-Biroulet L, Loftus EV, Colombel JF, Sandborn WJ. Early Crohn disease: a proposed definition for use in disease-modification trials. Gut. 2010 Feb; 59(2):141-7.
      View in: PubMed
    121. Dignass A, Van Assche G, Lindsay JO, Lémann M, Söderholm J, Colombel JF, Danese S, D'Hoore A, Gassull M, Gomollón F, Hommes DW, Michetti P, O'Morain C, Oresland T, Windsor A, Stange EF, Travis SP. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis. 2010 Feb; 4(1):28-62.
      View in: PubMed
    122. Peyrin-Biroulet L, Cieza A, Sandborn WJ, Kostanjsek N, Kamm MA, Hibi T, Lémann M, Stucki G, Colombel JF. Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health. Inflamm Bowel Dis. 2010 Jan; 16(1):15-22.
      View in: PubMed
    123. Allez M, Vermeire S, Mozziconacci N, Michetti P, Laharie D, Louis E, Bigard MA, Hébuterne X, Treton X, Kohn A, Marteau P, Cortot A, Nichita C, van Assche G, Rutgeerts P, Lémann M, Colombel JF. The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies. Aliment Pharmacol Ther. 2010 Jan; 31(1):92-101.
      View in: PubMed
    124. Rahier JF, Yazdanpanah Y, Viget N, Travis S, Colombel JF. Review article: influenza A (H1N1) virus in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2010 Jan; 31(1):5-10.
      View in: PubMed
    125. Joossens M, Van Steen K, Branche J, Sendid B, Rutgeerts P, Vasseur F, Poulain D, Broly F, Colombel JF, Vermeire S, Chamaillard M. Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn's disease. Inflamm Bowel Dis. 2010 Jan; 16(1):58-67.
      View in: PubMed
    126. Pineton de Chambrun G, Peyrin-Biroulet L, Lémann M, Colombel JF. Clinical implications of mucosal healing for the management of IBD. Nat Rev Gastroenterol Hepatol. 2010 Jan; 7(1):15-29.
      View in: PubMed
    127. Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009 Nov 7; 374(9701):1617-25.
      View in: PubMed
    128. Peyrin-Biroulet L, Loftus EV, Colombel JF, Sandborn WJ. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol. 2010 Feb; 105(2):289-97.
      View in: PubMed
    129. Parmentier-Decrucq E, Duhamel A, Ernst O, Fermont C, Louvet A, Vernier-Massouille G, Cortot A, Colombel JF, Desreumaux P, Peyrin-Biroulet L. Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease. Inflamm Bowel Dis. 2009 Oct; 15(10):1476-84.
      View in: PubMed
    130. Colombel JF, Sandborn WJ, Panaccione R, Robinson AM, Lau W, Li J, Cardoso AT. Adalimumab safety in global clinical trials of patients with Crohn's disease. Inflamm Bowel Dis. 2009 Sep; 15(9):1308-19.
      View in: PubMed
    131. Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson A, Johanns J, Lu J, Horgan K, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology. 2009 Oct; 137(4):1250-60; quiz 1520.
      View in: PubMed
    132. Bourreille A, Ignjatovic A, Aabakken L, Loftus EV, Eliakim R, Pennazio M, Bouhnik Y, Seidman E, Keuchel M, Albert JG, Ardizzone S, Bar-Meir S, Bisschops R, Despott EJ, Fortun PF, Heuschkel R, Kammermeier J, Leighton JA, Mantzaris GJ, Moussata D, Lo S, Paulsen V, Panés J, Radford-Smith G, Reinisch W, Rondonotti E, Sanders DS, Swoger JM, Yamamoto H, Travis S, Colombel JF, Van Gossum A. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy. 2009 Jul; 41(7):618-37.
      View in: PubMed
    133. Peyrin-Biroulet L, Colombel JF. Ulcerative colitis: Natural history--an optimistic message from Norway. Nat Rev Gastroenterol Hepatol. 2009 Jul; 6(7):387-8.
      View in: PubMed
    134. Branche J, Cortot A, Bourreille A, Coffin B, de Vos M, de Saussure P, Seksik P, Marteau P, Lemann M, Colombel JF. Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy. Inflamm Bowel Dis. 2009 Jul; 15(7):1044-8.
      View in: PubMed
    135. Peyrin-Biroulet L, Deltenre P, Ardizzone S, D'Haens G, Hanauer SB, Herfarth H, Lémann M, Colombel JF. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis. Am J Gastroenterol. 2009 Aug; 104(8):2089-96.
      View in: PubMed
    136. Standaert-Vitse A, Sendid B, Joossens M, François N, Vandewalle-El Khoury P, Branche J, Van Kruiningen H, Jouault T, Rutgeerts P, Gower-Rousseau C, Libersa C, Neut C, Broly F, Chamaillard M, Vermeire S, Poulain D, Colombel JF. Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol. 2009 Jul; 104(7):1745-53.
      View in: PubMed
    137. Peyrin-Biroulet L, Colombel JF, Sandborn WJ. Insufficient evidence to conclude whether anti-tumor necrosis factor therapy increases the risk of lymphoma in Crohn's disease. Clin Gastroenterol Hepatol. 2009 Oct; 7(10):1139.
      View in: PubMed
    138. Hervé S, Beaugerie L, Bouhnik Y, Savoye G, Colombel JF, Dyard F, Hourmand-Ollivier I, Dao T, Vial M, Lerebours E. Irritable bowel syndrome is more frequent in patients hospitalized for ischaemic colitis: results of a case-control study. Neurogastroenterol Motil. 2009 Nov; 21(11):1170-e102.
      View in: PubMed
    139. Gower-Rousseau C, Dauchet L, Vernier-Massouille G, Tilloy E, Brazier F, Merle V, Dupas JL, Savoye G, Baldé M, Marti R, Lerebours E, Cortot A, Salomez JL, Turck D, Colombel JF. The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol. 2009 Aug; 104(8):2080-8.
      View in: PubMed
    140. Sendid B, Jouault T, Vitse A, Fradin C, Colombel JF, Poulain D. [Anti-glycan antibodies establish an unexpected link between C. albicans and Crohn disease]. Med Sci (Paris). 2009 May; 25(5):473-81.
      View in: PubMed
    141. Rahier JF, Ben-Horin S, Chowers Y, Conlon C, De Munter P, D'Haens G, Domènech E, Eliakim R, Eser A, Frater J, Gassull M, Giladi M, Kaser A, Lémann M, Moreels T, Moschen A, Pollok R, Reinisch W, Schunter M, Stange EF, Tilg H, Van Assche G, Viget N, Vucelic B, Walsh A, Weiss G, Yazdanpanah Y, Zabana Y, Travis SP, Colombel JF. European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2009 Jun; 3(2):47-91.
      View in: PubMed
    142. Colombel JF, Sandborn WJ, Rutgeerts P, Kamm MA, Yu AP, Wu EQ, Pollack PF, Lomax KG, Chao J, Mulani PM. Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial. Am J Gastroenterol. 2009 May; 104(5):1170-9.
      View in: PubMed
    143. Wartel F, Maunoury V, Bulois P, Papadopoulos S, Filoche B, Colombel JF. Small-bowel ulcerations at wireless capsule endoscopy: go the whole way. BMJ Case Rep. 2009; 2009:bcr2006097733.
      View in: PubMed
    144. Colombel JF, Schwartz DA, Sandborn WJ, Kamm MA, D'Haens G, Rutgeerts P, Enns R, Panaccione R, Schreiber S, Li J, Kent JD, Lomax KG, Pollack PF. Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut. 2009 Jul; 58(7):940-8.
      View in: PubMed
    145. Thiébaut R, Kotti S, Jung C, Merlin F, Colombel JF, Lemann M, Almer S, Tysk C, O'Morain M, Gassull M, Binder V, Finkel Y, Pascoe L, Hugot JP. TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohort. Am J Gastroenterol. 2009 Feb; 104(2):384-91.
      View in: PubMed
    146. Pineton de Chambrun G, Vernier-Massouille G, Viget N, Colombel JF, Yazdanpanah Y. Is detection of JC virus DNA in blood a valuable screening test for progressive multifocal leukoencephalopathy in Crohn's disease patients eligible for anti-alpha4 integrin therapy? Gut. 2008 Nov; 57(11):1633-4; author reply 1634.
      View in: PubMed
    147. Loftus EV, Feagan BG, Colombel JF, Rubin DT, Wu EQ, Yu AP, Pollack PF, Chao J, Mulani P. Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial. Am J Gastroenterol. 2008 Dec; 103(12):3132-41.
      View in: PubMed
    148. Treton X, Bouhnik Y, Mary JY, Colombel JF, Duclos B, Soule JC, Lerebours E, Cosnes J, Lemann M. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse. Clin Gastroenterol Hepatol. 2009 Jan; 7(1):80-5.
      View in: PubMed
    149. Peyrin-Biroulet L, Desreumaux P, Sandborn WJ, Colombel JF. Crohn's disease: beyond antagonists of tumour necrosis factor. Lancet. 2008 Jul 5; 372(9632):67-81.
      View in: PubMed
    150. Vernier-Massouille G, Balde M, Salleron J, Turck D, Dupas JL, Mouterde O, Merle V, Salomez JL, Branche J, Marti R, Lerebours E, Cortot A, Gower-Rousseau C, Colombel JF. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology. 2008 Oct; 135(4):1106-13.
      View in: PubMed
    151. Pineton de Chambrun G, Colombel JF, Poulain D, Darfeuille-Michaud A. Pathogenic agents in inflammatory bowel diseases. Curr Opin Gastroenterol. 2008 Jul; 24(4):440-7.
      View in: PubMed
    152. Piton G, Cosnes J, Monnet E, Beaugerie L, Seksik P, Savoye G, Cadiot G, Flourie B, Capelle P, Marteau P, Lemann M, Colombel JF, Khouri E, Bonaz B, Carbonnel F. Risk factors associated with small bowel adenocarcinoma in Crohn's disease: a case-control study. Am J Gastroenterol. 2008 Jul; 103(7):1730-6.
      View in: PubMed
    153. Peyrin-Biroulet L, Deltenre P, de Suray N, Branche J, Sandborn WJ, Colombel JF. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol. 2008 Jun; 6(6):644-53.
      View in: PubMed
    154. Geboes K, Colombel JF, Greenstein A, Jewell DP, Sandborn WJ, Vatn MH, Warren B, Riddell RH. Indeterminate colitis: a review of the concept--what's in a name? Inflamm Bowel Dis. 2008 Jun; 14(6):850-7.
      View in: PubMed
    155. Darfeuille-Michaud A, Colombel JF. Pathogenic Escherichia coli in inflammatory bowel diseases Proceedings of the 1st International Meeting on E. coli and IBD, June 2007, Lille, France. J Crohns Colitis. 2008 Sep; 2(3):255-62.
      View in: PubMed
    156. Colombel JF. Efficacy and safety of adalimumab for the treatment of Crohn's disease in adults. Expert Rev Gastroenterol Hepatol. 2008 Apr; 2(2):163-76.
      View in: PubMed
    157. Hejazi R, Colombel JF, Peyrin-Biroulet L. [Retrobulbar optic neuritis during infliximab treatment for ulcerative colitis]. Gastroenterol Clin Biol. 2008 Feb; 32(2):162-3.
      View in: PubMed
    158. Cosnes J, Cellier C, Viola S, Colombel JF, Michaud L, Sarles J, Hugot JP, Ginies JL, Dabadie A, Mouterde O, Allez M, Nion-Larmurier I. Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol. 2008 Jul; 6(7):753-8.
      View in: PubMed
    159. Travis SP, Stange EF, Lémann M, Oresland T, Bemelman WA, Chowers Y, Colombel JF, D'Haens G, Ghosh S, Marteau P, Kruis W, Mortensen NJ, Penninckx F, Gassull M. European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis. 2008 Mar; 2(1):24-62.
      View in: PubMed
    160. Toruner M, Loftus EV, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, Colombel JF, Egan LJ. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008 Apr; 134(4):929-36.
      View in: PubMed
    161. Viget N, Vernier-Massouille G, Salmon-Ceron D, Yazdanpanah Y, Colombel JF. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut. 2008 Apr; 57(4):549-58.
      View in: PubMed
    162. Van Kruiningen HJ, Colombel JF. The forgotten role of lymphangitis in Crohn's disease. Gut. 2008 Jan; 57(1):1-4.
      View in: PubMed
    163. Colombel JF, Watson AJ, Neurath MF. The 10 remaining mysteries of inflammatory bowel disease. Gut. 2008 Apr; 57(4):429-33.
      View in: PubMed
    164. Van Kruiningen HJ, Joossens M, Colombel JF. Cluster of Crohn's disease in Herny, France, including 2 cases from a common residence. Inflamm Bowel Dis. 2007 Nov; 13(11):1454-5.
      View in: PubMed
    165. Reumaux D, Bardin N, Colombel JF, Dignat-George F, Duthilleul P, Vermeire S. Restoration of soluble CD146 in patients with Crohn's disease treated with the TNF-alpha antagonist infliximab. Inflamm Bowel Dis. 2007 Oct; 13(10):1315-7.
      View in: PubMed
    166. Fleyfel M, Dusson C, Ousmane ML, Guidat A, Colombel JF, Gambiez L, Vallet B. Inflammation affects sufentanil consumption in ulcerative colitis. Eur J Anaesthesiol. 2008 Mar; 25(3):188-92.
      View in: PubMed
    167. Reinisch W, Sandborn WJ, Bala M, Yan S, Feagan BG, Rutgeerts P, Radford-Smith G, Xu S, Eisenberg D, Olson A, Colombel JF. Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis. Inflamm Bowel Dis. 2007 Sep; 13(9):1135-40.
      View in: PubMed
    168. Van Kruiningen HJ, Poulin M, Garmendia AE, Desreumaux P, Colombel JF, De Hertogh G, Geboes K, Vermeire S, Tsongalis GJ. Search for evidence of recurring or persistent viruses in Crohn's disease. APMIS. 2007 Aug; 115(8):962-8.
      View in: PubMed
    169. Clark M, Colombel JF, Feagan BC, Fedorak RN, Hanauer SB, Kamm MA, Mayer L, Regueiro C, Rutgeerts P, Sandborn WJ, Sands BE, Schreiber S, Targan S, Travis S, Vermeire S. American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Gastroenterology. 2007 Jul; 133(1):312-39.
      View in: PubMed
    170. Colombel JF, Vernier-Massouille G, Cortot A, Gower-Rousseau C, Salomez JL. [Epidemiology and risk factors of inflammatory bowel diseases]. Bull Acad Natl Med. 2007 Jun; 191(6):1105-18; discussion 1118-23.
      View in: PubMed
    171. Peyrin-Biroulet L, Neut C, Colombel JF. Antimycobacterial therapy in Crohn's disease: game over? Gastroenterology. 2007 Jun; 132(7):2594-8.
      View in: PubMed
    172. Barnich N, Carvalho FA, Glasser AL, Darcha C, Jantscheff P, Allez M, Peeters H, Bommelaer G, Desreumaux P, Colombel JF, Darfeuille-Michaud A. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest. 2007 Jun; 117(6):1566-74.
      View in: PubMed
    173. Vernier-Massouille G, Cosnes J, Lemann M, Marteau P, Reinisch W, Laharie D, Cadiot G, Bouhnik Y, De Vos M, Boureille A, Duclos B, Seksik P, Mary JY, Colombel JF. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut. 2007 Oct; 56(10):1404-9.
      View in: PubMed
    174. André MF, Piette JC, Kémény JL, Ninet J, Jego P, Delèvaux I, Wechsler B, Weiller PJ, Francès C, Blétry O, Wismans PJ, Rousset H, Colombel JF, Aumaître O. Aseptic abscesses: a study of 30 patients with or without inflammatory bowel disease and review of the literature. Medicine (Baltimore). 2007 May; 86(3):145-61.
      View in: PubMed
    175. Adenis A, Vanseymortier L, Foissey D, Colombel JF. Bevacizumab and postponed suture leakages after surgery for ulcerative colitis and rectal cancer. Gut. 2007 May; 56(5):734.
      View in: PubMed
    176. Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Colombel JF, Panaccione R, D'Haens G, Li J, Rosenfeld MR, Kent JD, Pollack PF. Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial. Ann Intern Med. 2007 Jun 19; 146(12):829-38.
      View in: PubMed
    177. Maunoury V, Savoye G, Bourreille A, Bouhnik Y, Jarry M, Sacher-Huvelin S, Ben Soussan E, Lerebours E, Galmiche JP, Colombel JF. Value of wireless capsule endoscopy in patients with indeterminate colitis (inflammatory bowel disease type unclassified). Inflamm Bowel Dis. 2007 Feb; 13(2):152-5.
      View in: PubMed
    178. Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, Dubuquoy C, Merour E, Geboes K, Chamaillard M, Ouwehand A, Leyer G, Carcano D, Colombel JF, Ardid D, Desreumaux P. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med. 2007 Jan; 13(1):35-7.
      View in: PubMed
    179. Colombel JF, Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Panaccione R, Schreiber S, Byczkowski D, Li J, Kent JD, Pollack PF. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology. 2007 Jan; 132(1):52-65.
      View in: PubMed
    180. Lerebours E, Gower-Rousseau C, Merle V, Brazier F, Debeugny S, Marti R, Salomez JL, Hellot MF, Dupas JL, Colombel JF, Cortot A, Benichou J. Stressful life events as a risk factor for inflammatory bowel disease onset: A population-based case-control study. Am J Gastroenterol. 2007 Jan; 102(1):122-31.
      View in: PubMed
    181. Peyrin-Biroulet L, Chamaillard M, Gonzalez F, Beclin E, Decourcelle C, Antunes L, Gay J, Neut C, Colombel JF, Desreumaux P. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander? Gut. 2007 Apr; 56(4):577-83.
      View in: PubMed
    182. Colombel JF, Peyrin-Biroulet L. Natalizumab: a promising treatment for Crohn's disease. Expert Rev Clin Immunol. 2006 Sep; 2(5):677-89.
      View in: PubMed
    183. Duburque C, Lelong J, Iacob R, Seddik M, Desreumaux P, Fournier C, Wallaert B, Cortot A, Colombel JF. Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions. Aliment Pharmacol Ther. 2006 Sep 1; 24(5):851-8.
      View in: PubMed
    184. Malamut G, Cabane C, Dubuquoy L, Malapel M, Dérijard B, Gay J, Tamboli C, Colombel JF, Desreumaux P. No evidence for an involvement of the p38 and JNK mitogen-activated protein in inflammatory bowel diseases. Dig Dis Sci. 2006 Aug; 51(8):1443-53.
      View in: PubMed
    185. Consigny Y, Modigliani R, Colombel JF, Dupas JL, Lémann M, Mary JY. A simple biological score for predicting low risk of short-term relapse in Crohn's disease. Inflamm Bowel Dis. 2006 Jul; 12(7):551-7.
      View in: PubMed
    186. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006 Jun; 55(6):749-53.
      View in: PubMed
    187. Bougnoux ME, Diogo D, François N, Sendid B, Veirmeire S, Colombel JF, Bouchier C, Van Kruiningen H, d'Enfert C, Poulain D. Multilocus sequence typing reveals intrafamilial transmission and microevolutions of Candida albicans isolates from the human digestive tract. J Clin Microbiol. 2006 May; 44(5):1810-20.
      View in: PubMed
    188. Colombel JF, Solem CA, Sandborn WJ, Booya F, Loftus EV, Harmsen WS, Zinsmeister AR, Bodily KD, Fletcher JG. Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut. 2006 Nov; 55(11):1561-7.
      View in: PubMed
    189. Mortier PE, Gambiez L, Karoui M, Cortot A, Paris JC, Quandalle P, Colombel JF. Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis. Gastroenterol Clin Biol. 2006 Apr; 30(4):594-7.
      View in: PubMed
    190. Schreiber S, Feagan B, D'Haens G, Colombel JF, Geboes K, Yurcov M, Isakov V, Golovenko O, Bernstein CN, Ludwig D, Winter T, Meier U, Yong C, Steffgen J. Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2006 Mar; 4(3):325-34.
      View in: PubMed
    191. Rutgeerts P, Diamond RH, Bala M, Olson A, Lichtenstein GR, Bao W, Patel K, Wolf DC, Safdi M, Colombel JF, Lashner B, Hanauer SB. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc. 2006 Mar; 63(3):433-42; quiz 464.
      View in: PubMed
    192. Reinisch W, Hommes DW, Van Assche G, Colombel JF, Gendre JP, Oldenburg B, Teml A, Geboes K, Ding H, Zhang L, Tang M, Cheng M, van Deventer SJ, Rutgeerts P, Pearce T. A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease. Gut. 2006 Aug; 55(8):1138-44.
      View in: PubMed
    193. Chamaillard M, Iacob R, Desreumaux P, Colombel JF. Advances and perspectives in the genetics of inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2006 Feb; 4(2):143-51.
      View in: PubMed
    194. Bourreille A, Jarry M, D'Halluin PN, Ben-Soussan E, Maunoury V, Bulois P, Sacher-Huvelin S, Vahedy K, Lerebours E, Heresbach D, Bretagne JF, Colombel JF, Galmiche JP. Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn's disease: a prospective study. Gut. 2006 Jul; 55(7):978-83.
      View in: PubMed
    195. Mordon S, Maunoury V, Bulois P, Rochon P, Desreumaux P, Colombel JF. [Fluorescent imaging in digestive endoscopy]. Gastroenterol Clin Biol. 2006 Jan; 30(1):165-8.
      View in: PubMed
    196. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005 Dec 8; 353(23):2462-76.
      View in: PubMed
    197. Philippe D, Chakass D, Thuru X, Zerbib P, Tsicopoulos A, Geboes K, Bulois P, Breisse M, Vorng H, Gay J, Colombel JF, Desreumaux P, Chamaillard M. Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation. Gut. 2006 Jun; 55(6):815-23.
      View in: PubMed
    198. Sandborn WJ, Colombel JF, Enns R, Feagan BG, Hanauer SB, Lawrance IC, Panaccione R, Sanders M, Schreiber S, Targan S, van Deventer S, Goldblum R, Despain D, Hogge GS, Rutgeerts P. Natalizumab induction and maintenance therapy for Crohn's disease. N Engl J Med. 2005 Nov 3; 353(18):1912-25.
      View in: PubMed
    199. Mordon S, Maunoury V, Bulois P, Desreumaux P, Colombel JF. [Narrow band image videoendoscopy in gastroterology]. Gastroenterol Clin Biol. 2005 Nov; 29(11):1190-2.
      View in: PubMed
    200. Kornbluth A, Colombel JF, Leighton JA, Loftus E. ICCE consensus for inflammatory bowel disease. Endoscopy. 2005 Oct; 37(10):1051-4.
      View in: PubMed
    201. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, Jewell DP, Karban A, Loftus EV, Peña AS, Riddell RH, Sachar DB, Schreiber S, Steinhart AH, Targan SR, Vermeire S, Warren BF. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005 Sep; 19 Suppl A:5A-36A.
      View in: PubMed
    202. Auvin S, Molinié F, Gower-Rousseau C, Brazier F, Merle V, Grandbastien B, Marti R, Lerebours E, Dupas JL, Colombel JF, Salomez JL, Cortot A, Turck D. Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999). J Pediatr Gastroenterol Nutr. 2005 Jul; 41(1):49-55.
      View in: PubMed
    203. Seddik M, Melliez H, Seguy D, Viget N, Cortot A, Colombel JF. Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease. Inflamm Bowel Dis. 2005 Jun; 11(6):618-20.
      View in: PubMed
    204. Lémann M, Mary JY, Colombel JF, Duclos B, Soule JC, Lerebours E, Modigliani R, Bouhnik Y. A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. Gastroenterology. 2005 Jun; 128(7):1812-8.
      View in: PubMed
    205. Colombel JF. [Inflammatory bowel diseases: a disease of the century]. Rev Prat. 2005 May 15; 55(9):941-2.
      View in: PubMed
    206. Vernier G, Cortot A, Gower-Rousseau C, Salomez JL, Colombel JF. [Epidemiology and risk factors of inflammatory bowel diseases]. Rev Prat. 2005 May 15; 55(9):949-61.
      View in: PubMed
    207. Mordon S, Maunoury V, Bulois P, Desreumaux P, Colombel JF. [Optical coherence computed tomography in gastroenterology]. Gastroenterol Clin Biol. 2005 May; 29(5):618-20.
      View in: PubMed
    208. Halfvarson J, Standaert-Vitse A, Järnerot G, Sendid B, Jouault T, Bodin L, Duhamel A, Colombel JF, Tysk C, Poulain D. Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease. Gut. 2005 Sep; 54(9):1237-43.
      View in: PubMed
    209. Rousseaux C, Lefebvre B, Dubuquoy L, Lefebvre P, Romano O, Auwerx J, Metzger D, Wahli W, Desvergne B, Naccari GC, Chavatte P, Farce A, Bulois P, Cortot A, Colombel JF, Desreumaux P. Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. J Exp Med. 2005 Apr 18; 201(8):1205-15.
      View in: PubMed
    210. Van Kruiningen HJ, Joossens M, Vermeire S, Joossens S, Debeugny S, Gower-Rousseau C, Cortot A, Colombel JF, Rutgeerts P, Vlietinck R. Environmental factors in familial Crohn's disease in Belgium. Inflamm Bowel Dis. 2005 Apr; 11(4):360-5.
      View in: PubMed
    211. Lelong J, Duburque C, Fournier C, Colombel JF, Desreumaux P, Tonnel AB, Wallaert B. [Desensitisation to infliximab in patients with Crohn's disease]. Rev Mal Respir. 2005 Apr; 22(2 Pt 1):239-46.
      View in: PubMed
    212. Mordon S, Maunoury V, Bulois P, Desreumaux P, Colombel JF. [Confocal endoscopy]. Gastroenterol Clin Biol. 2005 Mar; 29(3):314-8.
      View in: PubMed
    213. Baron S, Turck D, Leplat C, Merle V, Gower-Rousseau C, Marti R, Yzet T, Lerebours E, Dupas JL, Debeugny S, Salomez JL, Cortot A, Colombel JF. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut. 2005 Mar; 54(3):357-63.
      View in: PubMed
    214. Maunoury V, Breisse M, Desreumaux P, Gambiez L, Colombel JF. Infliximab failure in cap polyposis. Gut. 2005 Feb; 54(2):313-4.
      View in: PubMed
    215. Cauffiez C, Klinzig F, Rat E, Tournel G, Allorge D, Chevalier D, Pottier N, Lovecchio T, Colombel JF, Lhermitte M, Lo-Guidice JM, Broly F. Human CYP4F12 genetic polymorphism: identification and functional characterization of seven variant allozymes. Biochem Pharmacol. 2004 Dec 15; 68(12):2417-25.
      View in: PubMed
    216. Yakoub-Agha I, Maunoury V, Wacrenier A, Couignoux S, Depil S, Desreumaux P, Bauters F, Colombel JF, Jouet JP. Impact of Small Bowel Exploration Using Video-Capsule Endoscopy in the Management of Acute Gastrointestinal Graft-versus-Host Disease. Transplantation. 2004 Dec 15; 78(11):1697-701.
      View in: PubMed
    217. Vernier G, Sendid B, Poulain D, Colombel JF. Relevance of serologic studies in inflammatory bowel disease. Curr Gastroenterol Rep. 2004 Dec; 6(6):482-7.
      View in: PubMed
    218. Annese V, Piepoli A, Perri F, Lombardi G, Latiano A, Napolitano G, Corritore G, Vandewalle P, Poulain D, Colombel JF, Andriulli A. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features. Aliment Pharmacol Ther. 2004 Nov 15; 20(10):1143-52.
      View in: PubMed
    219. Mangin I, Bonnet R, Seksik P, Rigottier-Gois L, Sutren M, Bouhnik Y, Neut C, Collins MD, Colombel JF, Marteau P, Doré J. Molecular inventory of faecal microflora in patients with Crohn's disease. FEMS Microbiol Ecol. 2004 Oct 1; 50(1):25-36.
      View in: PubMed
    220. Daperno M, D'Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, Sostegni R, Rocca R, Pera A, Gevers A, Mary JY, Colombel JF, Rutgeerts P. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc. 2004 Oct; 60(4):505-12.
      View in: PubMed
    221. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel JF. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004 Aug; 127(2):412-21.
      View in: PubMed
    222. Seddik M, Meliez H, Seguy D, Viget N, Cortot A, Colombel JF. Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease. Inflamm Bowel Dis. 2004 Jul; 10(4):436-7.
      View in: PubMed
    223. Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis as a prerequisite for IBD. Gut. 2004 Jul; 53(7):1057.
      View in: PubMed
    224. Cauffiez C, Klinzig F, Rat E, Tournel G, Allorge D, Chevalier D, Lovecchio T, Pottier N, Colombel JF, Lhermitte M, D'Halluin JC, Broly F, Lo-Guidice JM. Functional characterization of genetic polymorphisms identified in the human cytochrome P450 4F12 (CYP4F12) promoter region. Biochem Pharmacol. 2004 Jun 15; 67(12):2231-8.
      View in: PubMed
    225. Molinié F, Gower-Rousseau C, Yzet T, Merle V, Grandbastien B, Marti R, Lerebours E, Dupas JL, Colombel JF, Salomez JL, Cortot A. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut. 2004 Jun; 53(6):843-8.
      View in: PubMed
    226. Colombel JF, Loftus EV, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol. 2004 May; 99(5):878-83.
      View in: PubMed
    227. Cocq P, Yazdanpannah Y, Mesnard B, Colombel JF. [Anti-TNF agents in inflammatory bowel disease: indications and management]. Gastroenterol Clin Biol. 2004 May; 28(5 Suppl):D61-9.
      View in: PubMed
    228. Cauffiez C, Lo-Guidice JM, Quaranta S, Allorge D, Chevalier D, Cenée S, Hamdan R, Lhermitte M, Lafitte JJ, Libersa C, Colombel JF, Stücker I, Broly F. Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility. Biochem Biophys Res Commun. 2004 Apr 30; 317(2):662-9.
      View in: PubMed
    229. Louis E, El Ghoul Z, Vermeire S, Dall'Ozzo S, Rutgeerts P, Paintaud G, Belaiche J, De Vos M, Van Gossum A, Colombel JF, Watier H. Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease. Aliment Pharmacol Ther. 2004 Mar 1; 19(5):511-9.
      View in: PubMed
    230. Rutgeerts P, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Hanauer SB. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology. 2004 Feb; 126(2):402-13.
      View in: PubMed
    231. Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis in inflammatory bowel disease. Gut. 2004 Jan; 53(1):1-4.
      View in: PubMed
    232. Lepers S, Couignoux S, Colombel JF, Dubucquoi S. [Celiac disease in adults: new aspects]. Rev Med Interne. 2004 Jan; 25(1):22-34.
      View in: PubMed
    233. Cauffiez C, Lo-Guidice JM, Chevalier D, Allorge D, Hamdan R, Lhermitte M, Lafitte JJ, Colombel JF, Libersa C, Broly F. First report of a genetic polymorphism of the cytochrome P450 3A43 (CYP3A43) gene: identification of a loss-of-function variant. Hum Mutat. 2004 Jan; 23(1):101.
      View in: PubMed
    234. Colombel JF, Loftus EV, Tremaine WJ, Egan LJ, Harmsen WS, Schleck CD, Zinsmeister AR, Sandborn WJ. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology. 2004 Jan; 126(1):19-31.
      View in: PubMed
    235. Tilg H, Vogelsang H, Ludwiczek O, Lochs H, Kaser A, Colombel JF, Ulmer H, Rutgeerts P, Krüger S, Cortot A, D'Haens G, Harrer M, Gasche C, Wrba F, Kuhn I, Reinisch W. A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. Gut. 2003 Dec; 52(12):1728-33.
      View in: PubMed
    236. Guidat A, Fleyfel M, Vallet B, Desreumaux P, Levron JC, Gambiez L, Colombel JF, Scherpereel P. Inflammation increases sufentanil requirements during surgery for inflammatory bowel diseases. Eur J Anaesthesiol. 2003 Dec; 20(12):957-62.
      View in: PubMed
    237. Hamdan-Khalil R, Allorge D, Lo-Guidice JM, Cauffiez C, Chevalier D, Spire C, Houdret N, Libersa C, Lhermitte M, Colombel JF, Gala JL, Broly F. In vitro characterization of four novel non-functional variants of the thiopurine S-methyltransferase. Biochem Biophys Res Commun. 2003 Oct 3; 309(4):1005-10.
      View in: PubMed
    238. Colombel JF, Ricart E, Loftus EV, Tremaine WJ, Young-Fadok T, Dozois EJ, Wolff BG, Devine R, Pemberton JH, Sandborn WJ. Management of Crohn's disease of the ileoanal pouch with infliximab. Am J Gastroenterol. 2003 Oct; 98(10):2239-44.
      View in: PubMed
    239. Tamboli CP, Caucheteux C, Cortot A, Colombel JF, Desreumaux P. Probiotics in inflammatory bowel disease: a critical review. Best Pract Res Clin Gastroenterol. 2003 Oct; 17(5):805-20.
      View in: PubMed
    240. Barthet M, Dubucquoy L, Garcia S, Gasmi M, Desreumaux P, Colombel JF, Grimaud JC, Iovanna J, Dagorn JC. Pancreatic changes in TNBS-induced colitis in mice. Gastroenterol Clin Biol. 2003 Oct; 27(10):895-900.
      View in: PubMed
    241. Ferrier L, Mazelin L, Cenac N, Desreumaux P, Janin A, Emilie D, Colombel JF, Garcia-Villar R, Fioramonti J, Bueno L. Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice. Gastroenterology. 2003 Sep; 125(3):795-804.
      View in: PubMed
    242. Bonaz B, Boitard J, Marteau P, Lémann M, Coffin B, Flourié B, Belaiche J, Cadiot G, Metman EH, Cortot A, Colombel JF. Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine. Aliment Pharmacol Ther. 2003 Aug 15; 18(4):401-8.
      View in: PubMed
    243. Desreumaux P, Colombel JF. [Intestinal flora and Crohn's disease]. Ann Pharm Fr. 2003 Jul; 61(4):276-81.
      View in: PubMed
    244. Boudeau J, Glasser AL, Julien S, Colombel JF, Darfeuille-Michaud A. Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease. Aliment Pharmacol Ther. 2003 Jul 1; 18(1):45-56.
      View in: PubMed
    245. Tamboli CP, Cortot A, Colombel JF. What are the major arguments in favour of the genetic susceptibility for inflammatory bowel disease? Eur J Gastroenterol Hepatol. 2003 Jun; 15(6):587-92.
      View in: PubMed
    246. Dubuquoy L, Jansson EA, Deeb S, Rakotobe S, Karoui M, Colombel JF, Auwerx J, Pettersson S, Desreumaux P. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology. 2003 May; 124(5):1265-76.
      View in: PubMed
    247. Philippe D, Dubuquoy L, Groux H, Brun V, Chuoï-Mariot MT, Gaveriaux-Ruff C, Colombel JF, Kieffer BL, Desreumaux P. Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. J Clin Invest. 2003 May; 111(9):1329-38.
      View in: PubMed
    248. Bourreille A, Doubremelle M, Colombel JF. [Antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae mannan antibodies: new biological tools for diagnosis of inflammatory bowel disease]. Rev Med Interne. 2003 Mar; 24(3):147-50.
      View in: PubMed
    249. Desreumaux P, Bourreille A, Colombel JF. [Physiopathology of inflammatory bowel diseases: new biological tools for disease diagnosis and monitoring?]. Gastroenterol Clin Biol. 2003 Mar; 27(3 Suppl):S81-6.
      View in: PubMed
    250. Reumaux D, Sendid B, Poulain D, Duthilleul P, Dewit O, Colombel JF. Serological markers in inflammatory bowel diseases. Best Pract Res Clin Gastroenterol. 2003 Feb; 17(1):19-35.
      View in: PubMed
    251. Colombel JF. The CARD15 (also known as NOD2) gene in Crohn's disease: are there implications for current clinical practice? Clin Gastroenterol Hepatol. 2003 Jan; 1(1):5-9.
      View in: PubMed
    252. Thevenot T, Mathurin P, Di Martino V, Nguyen-Khac E, Canva-Delcambre V, Campin G, Cortot A, Colombel JF, Paris JC. [Celiac disease and liver involvement]. Gastroenterol Clin Biol. 2003 Jan; 27(1):28-42.
      View in: PubMed
    253. Zouali H, Lesage S, Merlin F, Cézard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Christensen S, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Chamaillard M, Thomas G, Hugot JP. CARD4/NOD1 is not involved in inflammatory bowel disease. Gut. 2003 Jan; 52(1):71-4.
      View in: PubMed
    254. Nutten S, Sansonetti P, Huet G, Bourdon-Bisiaux C, Meresse B, Colombel JF, Desreumaux P. Epithelial inflammation response induced by Shigella flexneri depends on mucin gene expression. Microbes Infect. 2002 Sep; 4(11):1121-4.
      View in: PubMed
    255. Vermeire S, Louis E, Rutgeerts P, De Vos M, Van Gossum A, Belaiche J, Pescatore P, Fiasse R, Pelckmans P, Vlietinck R, Merlin F, Zouali H, Thomas G, Colombel JF, Hugot JP. NOD2/CARD15 does not influence response to infliximab in Crohn's disease. Gastroenterology. 2002 Jul; 123(1):106-11.
      View in: PubMed
    256. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002 May 4; 359(9317):1541-9.
      View in: PubMed
    257. Joossens S, Reinisch W, Vermeire S, Sendid B, Poulain D, Peeters M, Geboes K, Bossuyt X, Vandewalle P, Oberhuber G, Vogelsang H, Rutgeerts P, Colombel JF. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology. 2002 May; 122(5):1242-7.
      View in: PubMed
    258. Lesage S, Zouali H, Cézard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002 Apr; 70(4):845-57.
      View in: PubMed
    259. Meresse B, Rutgeerts P, Malchow H, Dubucquoi S, Dessaint JP, Cohard M, Colombel JF, Desreumaux P. Low ileal interleukin 10 concentrations are predictive of endoscopic recurrence in patients with Crohn's disease. Gut. 2002 Jan; 50(1):25-8.
      View in: PubMed
    260. Ouraghi A, Nieuviarts S, Mougenel JL, Allez M, Barthet M, Carbonnel F, Cosnes J, Gendre JP, Flourié B, Meurisse JJ, Quandalle P, Ernst O, Lemann M, Cortot A, Modigliani R, Colombel JF. [Infliximab therapy for Crohn's disease anoperineal lesions]. Gastroenterol Clin Biol. 2001 Nov; 25(11):949-56.
      View in: PubMed
    261. Cornet A, Savidge TC, Cabarrocas J, Deng WL, Colombel JF, Lassmann H, Desreumaux P, Liblau RS. Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease? Proc Natl Acad Sci U S A. 2001 Nov 6; 98(23):13306-11.
      View in: PubMed
    262. Buisine MP, Desreumaux P, Leteurtre E, Copin MC, Colombel JF, Porchet N, Aubert JP. Mucin gene expression in intestinal epithelial cells in Crohn's disease. Gut. 2001 Oct; 49(4):544-51.
      View in: PubMed
    263. Huglo D, De Botton S, Canva-Delcambre V, Colombel JF, Wallaert B, Steinling M, Marchandise X. Simultaneous determination of pulmonary and intestinal permeability in patients with alcoholic liver cirrhosis. Eur J Nucl Med. 2001 Oct; 28(10):1505-11.
      View in: PubMed
    264. Zouali H, Chamaillard M, Lesage S, Cézard JP, Colombel JF, Belaiche J, Almer S, Tysk C, Montague S, Gassull M, Christensen S, Finkel Y, Gower-Rousseau C, Modigliani R, Macry J, Selinger-Leneman H, Thomas G, Hugot JP. Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease. Eur J Hum Genet. 2001 Oct; 9(10):731-42.
      View in: PubMed
    265. Desreumaux P, Colombel JF. [Intestinal microflora and chronic inflammatory bowel diseases]. Gastroenterol Clin Biol. 2001 Sep; 25(2 Pt 2):C89-93.
      View in: PubMed
    266. Annese V, Andreoli A, Andriulli A, Dinca R, Gionchetti P, Latiano A, Lombardi G, Piepoli A, Poulain D, Sendid B, Colombel JF. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study. Am J Gastroenterol. 2001 Aug; 96(8):2407-12.
      View in: PubMed
    267. Sandborn WJ, Loftus EV, Colombel JF, Fleming KA, Seibold F, Homburger HA, Sendid B, Chapman RW, Tremaine WJ, Kaul DK, Wallace J, Harmsen WS, Zinsmeister AR, Targan SR. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2001 Aug; 7(3):192-201.
      View in: PubMed
    268. Colombel JF, Rutgeerts P, Malchow H, Jacyna M, Nielsen OH, Rask-Madsen J, Van Deventer S, Ferguson A, Desreumaux P, Forbes A, Geboes K, Melani L, Cohard M. Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease. Gut. 2001 Jul; 49(1):42-6.
      View in: PubMed
    269. Meresse B, Dubucquoi S, Tourvieille B, Desreumaux P, Colombel JF, Dessaint JP. CD28+ intraepithelial lymphocytes with long telomeres are recruited within the inflamed ileal mucosa in Crohn disease. Hum Immunol. 2001 Jul; 62(7):694-700.
      View in: PubMed
    270. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001 May 31; 411(6837):599-603.
      View in: PubMed
    271. Seddik M, Turck D, Gottrand F, Colombel JF. [Outcome in adulthood of children and adolescents with chronic intestinal inflammatory diseases]. Arch Pediatr. 2001 May; 8 Suppl 2:221s-223s.
      View in: PubMed
    272. Colombel JF, Cortot A, van Kruiningen HJ. Antibiotics in Crohn's disease. Gut. 2001 May; 48(5):647.
      View in: PubMed
    273. Van Kruiningen HJ, Cortot A, Colombel JF. The importance of familial clusterings in Crohn's disease. Inflamm Bowel Dis. 2001 May; 7(2):170-3; discussion 174.
      View in: PubMed
    274. Desreumaux P, Dubuquoy L, Nutten S, Peuchmaur M, Englaro W, Schoonjans K, Derijard B, Desvergne B, Wahli W, Chambon P, Leibowitz MD, Colombel JF, Auwerx J. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J Exp Med. 2001 Apr 2; 193(7):827-38.
      View in: PubMed
    275. Lamblin C, Desreumaux P, Colombel JF, Tonnel AB, Wallaert B. Overexpression of IL-10 mRNA in gut mucosa of patients with allergic asthma. J Allergy Clin Immunol. 2001 Apr; 107(4):739-41.
      View in: PubMed
    276. Laharie D, Debeugny S, Peeters M, Van Gossum A, Gower-Rousseau C, Bélaïche J, Fiasse R, Dupas JL, Lerebours E, Piotte S, Cortot A, Vermeire S, Grandbastien B, Colombel JF. Inflammatory bowel disease in spouses and their offspring. Gastroenterology. 2001 Mar; 120(4):816-9.
      View in: PubMed
    277. Masseret E, Boudeau J, Colombel JF, Neut C, Desreumaux P, Joly B, Cortot A, Darfeuille-Michaud A. Genetically related Escherichia coli strains associated with Crohn's disease. Gut. 2001 Mar; 48(3):320-5.
      View in: PubMed
    278. Cortot A, Colombel JF, Rutgeerts P, Lauritsen K, Malchow H, Hämling J, Winter T. Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease. Gut. 2001 Feb; 48(2):186-90.
      View in: PubMed
    279. Schreiber S, Campieri M, Colombel JF, van Deventer SJ, Feagan B, Fedorak R, Forbes A, Gassull M, Gendre JP, van Hogezand RA, Lofberg R, Modigliani R, Pallone F, Petritsch W, Prantera C, Rampton D, Seibold F, Vatn M, Zeitz M, Rutgeerts P. Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003. Int J Colorectal Dis. 2001 Feb; 16(1):1-11; discussion 12-3.
      View in: PubMed
    280. Renom G, Bulois P, Hafraoui S, Colombel JF, Degand PM. Simple gas chromatography analysis of faecal butyrate: application to patients at risk of pouchitis. Clin Chem Lab Med. 2001 Jan; 39(1):15-9.
      View in: PubMed
    281. Dombrowicz D, Nutten S, Desreumaux P, Neut C, Torpier G, Peeters M, Colombel JF, Capron M. Role of the high affinity immunoglobulin E receptor in bacterial translocation and intestinal inflammation. J Exp Med. 2001 Jan 1; 193(1):25-34.
      View in: PubMed
    282. Peeters M, Cortot A, Vermeire S, Colombel JF. Familial and sporadic inflammatory bowel disease: different entities? Inflamm Bowel Dis. 2000 Nov; 6(4):314-20.
      View in: PubMed
    283. Reumaux D, Colombel JF, Masy E, Duclos B, Heresbach D, Belaïche J, Cortot A, Duthilleul P. Anti-neutrophil cytoplasmic auto-antibodies (ANCA) in ulcerative colitis (UC): no relationship with disease activity. Inflamm Bowel Dis. 2000 Nov; 6(4):270-4.
      View in: PubMed
    284. Brandt E, Colombel JF, Ectors N, Gambiez L, Emilie D, Geboes K, Capron M, Desreumaux P. Enhanced production of IL-8 in chronic but not in early ileal lesions of Crohn's disease (CD). Clin Exp Immunol. 2000 Nov; 122(2):180-5.
      View in: PubMed
    285. Lebuffe G, Haddad E, Desreumaux P, Gambiez L, Colombel JF, Vallet B. Impaired contractile response of mesenteric arteries in Crohn's disease. Aliment Pharmacol Ther. 2000 Oct; 14(10):1279-85.
      View in: PubMed
    286. Maunoury V, Mordon S, Geboes K, Klein O, Debaert A, Cortot A, Desreumaux P, Colombel JF. Early vascular changes in Crohn's disease: an endoscopic fluorescence study. Endoscopy. 2000 Sep; 32(9):700-5.
      View in: PubMed
    287. Bulois P, Tremaine WJ, Maunoury V, Gambiez L, Hafraoui S, Leteurtre L, Cortot A, Sandborn WJ, Colombel JF, Desreumaux P. Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10. Inflamm Bowel Dis. 2000 Aug; 6(3):157-64.
      View in: PubMed
    288. Dubuquoy L, Bourdon C, Peuchmaur M, Leibowitz MD, Nutten S, Colombel JF, Auwerx J, Desreumaux P. [Peroxisome proliferator-activated receptor (PPAR) gamma: a new target for the treatment of inflammatory bowel disease]. Gastroenterol Clin Biol. 2000 Aug-Sep; 24(8-9):719-24.
      View in: PubMed
    289. Colombel JF, Ferrari N, Debuysere H, Marteau P, Gendre JP, Bonaz B, Soulé JC, Modigliani R, Touze Y, Catala P, Libersa C, Broly F. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology. 2000 Jun; 118(6):1025-30.
      View in: PubMed
    290. Jabri B, de Serre NP, Cellier C, Evans K, Gache C, Carvalho C, Mougenot JF, Allez M, Jian R, Desreumaux P, Colombel JF, Matuchansky C, Cugnenc H, Lopez-Botet M, Vivier E, Moretta A, Roberts AI, Ebert EC, Guy-Grand D, Brousse N, Schmitz J, Cerf-Bensussan N. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology. 2000 May; 118(5):867-79.
      View in: PubMed
    291. Lederman E, Petit ML, Boruchowicz A, Lecomte-Houcke M, Dewailly S, Colombel JF. [Cholesterol embolism: unusual cause of small intestine occlusion]. Gastroenterol Clin Biol. 2000 Feb; 24(2):225-7.
      View in: PubMed
    292. Desreumaux P, Nutten S, Colombel JF. Activated eosinophils in inflammatory bowel disease: do they matter? Am J Gastroenterol. 1999 Dec; 94(12):3396-8.
      View in: PubMed
    293. Taddei C, Audrain MA, Reumaux D, Sesboüe R, Testa A, Galmiche JP, Duthilleul P, Colombel JF, Esnault VL. Alpha1-antitrypsin phenotypes and anti-neutrophil cytoplasmic auto-antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1999 Nov; 11(11):1293-8.
      View in: PubMed
    294. Desreumaux P, Huet G, Zerimech F, Gambiez L, Balduyck M, Baron P, Degand P, Cortot A, Colombel JF, Janin A. Acute inflammatory intestinal vascular lesions and in situ abnormalities of the plasminogen activation system in Crohn's disease. Eur J Gastroenterol Hepatol. 1999 Oct; 11(10):1113-9.
      View in: PubMed
    295. Geboes K, Desreumaux P, Jouret A, Ectors N, Rutgeerts P, Colombel JF. [Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. Use of histological scores]. Gastroenterol Clin Biol. 1999 Oct; 23(10):1062-73.
      View in: PubMed
    296. Bulois P, Desreumaux P, Neut C, Darfeuille-Michaud A, Cortot A, Colombel JF. Infectious agents and Crohn's disease. Clin Microbiol Infect. 1999 Oct; 5(10):601-4.
      View in: PubMed
    297. Lefebvre M, Paulweber B, Fajas L, Woods J, McCrary C, Colombel JF, Najib J, Fruchart JC, Datz C, Vidal H, Desreumaux P, Auwerx J. Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells. J Endocrinol. 1999 Sep; 162(3):331-40.
      View in: PubMed
    298. Louvet B, Buisine MP, Desreumaux P, Tremaine WJ, Aubert JP, Porchet N, Capron M, Cortot A, Colombel JF, Sandborn WJ. Transdermal nicotine decreases mucosal IL-8 expression but has no effect on mucin gene expression in ulcerative colitis. Inflamm Bowel Dis. 1999 Aug; 5(3):174-81.
      View in: PubMed
    299. Desreumaux P, Ernst O, Geboes K, Gambiez L, Berrebi D, Müller-Alouf H, Hafraoui S, Emilie D, Ectors N, Peuchmaur M, Cortot A, Capron M, Auwerx J, Colombel JF. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology. 1999 Jul; 117(1):73-81.
      View in: PubMed
    300. Colombel JF, Laharie D, Grandbastien B. Anticipating the onset of inflammatory bowel disease. Gut. 1999 Jun; 44(6):773-4.
      View in: PubMed
    301. Bulois P, Lederman E, Desreumaux P, Cortot A, Colombel JF. [Role of antibiotics in Crohn's disease]. Gastroenterol Clin Biol. 1999 Jun; 23(5 Pt 2):B189-94.
      View in: PubMed
    302. Desreumaux P, Meresse B, Cortot A, Colombel JF. [Cytokines and anti-cytokines in chronic inflammatory intestinal diseases]. Gastroenterol Clin Biol. 1999 Jun; 23(5 Pt 2):B159-68.
      View in: PubMed
    303. Leteurtre E, Kosydar P, Gambiez L, Colombel JF, Quandalle P, Lecomte-Houcke M. [Excluded rectum during Crohn's diseases: what is the risk of dysplasia?]. Gastroenterol Clin Biol. 1999 Apr; 23(4):477-82.
      View in: PubMed
    304. Colombel JF, Lémann M, Cassagnou M, Bouhnik Y, Duclos B, Dupas JL, Notteghem B, Mary JY. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Am J Gastroenterol. 1999 Mar; 94(3):674-8.
      View in: PubMed
    305. Touze I, Gower-Rousseau C, Grandbastien B, Paris JC, Quandalle P, Cortot A, Colombel JF. [Diffuse jejuno-ileitis of Crohn's disease: a separate form of the disease?]. Gastroenterol Clin Biol. 1999 Mar; 23(3):307-11.
      View in: PubMed
    306. Buisine MP, Desreumaux P, Debailleul V, Gambiez L, Geboes K, Ectors N, Delescaut MP, Degand P, Aubert JP, Colombel JF, Porchet N. Abnormalities in mucin gene expression in Crohn's disease. Inflamm Bowel Dis. 1999 Feb; 5(1):24-32.
      View in: PubMed
    307. Brandt E, Müller-Alouf H, Desreumaux P, Woerly G, Colombel JF, Capron M. Circulating growth-regulator oncogene alpha contributes to neutrophil priming and interleukin-8-directed mucosal recruitment into chronic lesions of patients with Crohn's disease. Eur Cytokine Netw. 1998 Dec; 9(4):647-53.
      View in: PubMed
    308. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, Gambiez L, Joly B, Cortot A, Colombel JF. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology. 1998 Dec; 115(6):1405-13.
      View in: PubMed
    309. Spire-Vayron de la Moureyre C, Debuysere H, Mastain B, Vinner E, Marez D, Lo Guidice JM, Chevalier D, Brique S, Motte K, Colombel JF, Turck D, Noel C, Flipo RM, Pol A, Lhermitte M, Lafitte JJ, Libersa C, Broly F. Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population. Br J Pharmacol. 1998 Oct; 125(4):879-87.
      View in: PubMed
    310. Sendid B, Quinton JF, Charrier G, Goulet O, Cortot A, Grandbastien B, Poulain D, Colombel JF. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol. 1998 Aug; 93(8):1306-10.
      View in: PubMed
    311. Desreumaux P, Delaporte E, Colombel JF, Capron M, Cortot A, Janin A. Similar IL-5, IL-3, and GM-CSF syntheses by eosinophils in the jejunal mucosa of patients with celiac disease and dermatitis herpetiformis. Clin Immunol Immunopathol. 1998 Jul; 88(1):14-21.
      View in: PubMed
    312. Auber F, Gambiez L, Desreumaux P, Mudry J, Lecomte-Houcke M, Cortot A, Quandalle P, Colombel JF. Mixed adenocarcinoid tumor and Crohn's disease. J Clin Gastroenterol. 1998 Jun; 26(4):353-4.
      View in: PubMed
    313. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998 Jun; 42(6):788-91.
      View in: PubMed
    314. Mirza MM, Lee J, Teare D, Hugot JP, Laurent-Puig P, Colombel JF, Hodgson SV, Thomas G, Easton DF, Lennard-Jones JE, Mathew CG. Evidence of linkage of the inflammatory bowel disease susceptibility locus on chromosome 16 (IBD1) to ulcerative colitis. J Med Genet. 1998 Mar; 35(3):218-21.
      View in: PubMed
    315. Grandbastien B, Peeters M, Franchimont D, Gower-Rousseau C, Speckel D, Rutgeerts P, Belaïche J, Cortot A, Vlietinck R, Colombel JF. Anticipation in familial Crohn's disease. Gut. 1998 Feb; 42(2):170-4.
      View in: PubMed
    316. Dharancy S, Talbodec N, Asselah T, Hachulla E, Delaporte E, Cortot A, Colombel JF. [The synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome, a rare extra-digestive manifestation of Crohn's disease. Presentation of 1 case and review of the literature]. Gastroenterol Clin Biol. 1998 Feb; 22(2):240-3.
      View in: PubMed
    317. Colombel JF, Desreumaux P. [Pathogenesis: immunologic, infectious and genetic aspects]. Arch Pediatr. 1998; 5 Suppl 2:97s-100s.
      View in: PubMed
    318. Buisine MP, Colombel JF, Lecomte-Houcke M, Gower P, Aubert JP, Porchet N, Janin A. Abnormal mucus in cap polyposis. Gut. 1998 Jan; 42(1):135-8.
      View in: PubMed
    319. Hebbar M, Kozlowski D, Wattel E, Mastrini S, Diévart M, Duclos B, Bonaz B, d'Almagne H, Belaiche J, Colombel JF, Fenaux P. Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature. Leukemia. 1997 Dec; 11(12):2188-91.
      View in: PubMed
    320. Aldebert D, Masy E, Reumaux D, Lion G, Colombel JF, Duthilleul P. Immunoglobulin G subclass distribution of anti-endothelial cell antibodies (AECA) in patients with ulcerative colitis or Crohn's disease. Dig Dis Sci. 1997 Nov; 42(11):2350-5.
      View in: PubMed
    321. Heresbach D, Alizadeh M, Bretagne JF, Dabadie A, Colombel JF, Pagenault M, Heresbach-Le Berre N, Genetet B, Gosselin M, Semana G. TAP gene transporter polymorphism in inflammatory bowel diseases. Scand J Gastroenterol. 1997 Oct; 32(10):1022-7.
      View in: PubMed
    322. Yazdanpanah Y, Klein O, Gambiez L, Baron P, Desreumaux P, Marquis P, Cortot A, Quandalle P, Colombel JF. Impact of surgery on quality of life in Crohn's disease. Am J Gastroenterol. 1997 Oct; 92(10):1897-900.
      View in: PubMed
    323. Desreumaux P, Brandt E, Gambiez L, Emilie D, Geboes K, Klein O, Ectors N, Cortot A, Capron M, Colombel JF. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology. 1997 Jul; 113(1):118-26.
      View in: PubMed
    324. Heresbach D, Alizadeh M, Dabadie A, Le Berre N, Colombel JF, Yaouanq J, Bretagne JF, Semana G. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases. Am J Gastroenterol. 1997 Jul; 92(7):1164-9.
      View in: PubMed
    325. Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci. 1997 Apr; 42(4):817-22.
      View in: PubMed
    326. Boruchowicz A, Rey C, Fontaine M, Martin-Ponthieu A, Lecomte-Houcke M, West AB, Colombel JF. Colonic xanthelasma due to glyceride accumulation associated with an adenoma. Am J Gastroenterol. 1997 Jan; 92(1):159-61.
      View in: PubMed
    327. Lederman E, Boruchowicz A, Colombel JF. [Chronic pancreatitis: an extraintestinal manifestation of hemorrhagic rectocolitis?]. Gastroenterol Clin Biol. 1997; 21(1):71-3.
      View in: PubMed
    328. Vayre-Oundjian L, Boruchowicz A, Bloget F, Triboulet JP, Gosselin B, Colombel JF. [Pseudotumor nodular lymphoid hyperplasia of the ileum]. Gastroenterol Clin Biol. 1997; 21(12):990-3.
      View in: PubMed
    329. Gower-Rousseau C, Grandbastien B, Colombel JF, Cortot A. [Incidences of chronic inflammatory bowel diseases in France: the table is growing richer]. Gastroenterol Clin Biol. 1997; 21(6-7):481-2.
      View in: PubMed
    330. Carbonnel F, Boruchowicz A, Duclos B, Soulé JC, Lerebours E, Lémann M, Belaïche J, Colombel JF, Cosnes J, Gendre JP. Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses. Dig Dis Sci. 1996 Dec; 41(12):2471-6.
      View in: PubMed
    331. Heresbach D, Alizadeh M, Reumaux D, Colombel JF, Delamaire M, Danze PM, Gosselin M, Genetet B, Bretagne JF, Semana G. Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis? J Autoimmun. 1996 Dec; 9(6):777-84.
      View in: PubMed
    332. Boruchowicz A, Hachulla E, Cortot A, Paris JC, Colombel JF. Chronic pancreatitis: a complication of sarcoidosis? Eur J Gastroenterol Hepatol. 1996 Nov; 8(11):1125-7.
      View in: PubMed
    333. Canva-Delcambre V, Jacquot S, Robinet E, Lémann M, Drouet C, Labalette M, Dessaint JP, Bengoufa D, Rabian C, Modigliani R, Wijdenes J, Revillard JP, Colombel JF. Treatment of severe Crohn's disease with anti-CD4 monoclonal antibody. Aliment Pharmacol Ther. 1996 Oct; 10(5):721-7.
      View in: PubMed
    334. Colombel JF, Grandbastien B, Gower-Rousseau C, Plegat S, Evrard JP, Dupas JL, Gendre JP, Modigliani R, Bélaïche J, Hostein J, Hugot JP, van Kruiningen H, Cortot A. Clinical characteristics of Crohn's disease in 72 families. Gastroenterology. 1996 Sep; 111(3):604-7.
      View in: PubMed
    335. Danzé PM, Colombel JF, Jacquot S, Loste MN, Heresbach D, Ategbo S, Khamassi S, Périchon B, Semana G, Charron D, Cézard JP. Association of HLA class II genes with susceptibility to Crohn's disease. Gut. 1996 Jul; 39(1):69-72.
      View in: PubMed
    336. Maunoury V, Mordon S, Klein O, Colombel JF. Fluorescence endoscopic imaging study of anastomotic recurrence of Crohn's disease. Gastrointest Endosc. 1996 Jun; 43(6):603-4.
      View in: PubMed
    337. Lémann M, Chamiot-Prieur C, Mesnard B, Halphen M, Messing B, Rambaud JC, Gendre JP, Colombel JF, Modigliani R. Methotrexate for the treatment of refractory Crohn's disease. Aliment Pharmacol Ther. 1996 Jun; 10(3):309-14.
      View in: PubMed
    338. Desreumaux P, Levy A, Vaerman JP, Capron M, Cortot A, Colombel JF. Effect of intrajejunal elemental diet perfusion on local secretion of soluble CD4 and CD8. Clin Exp Immunol. 1996 May; 104(2):293-6.
      View in: PubMed
    339. Desreumaux P, Bloget F, Seguy D, Capron M, Cortot A, Colombel JF, Janin A. Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology. 1996 Mar; 110(3):768-74.
      View in: PubMed
    340. Sendid B, Colombel JF, Jacquinot PM, Faille C, Fruit J, Cortot A, Lucidarme D, Camus D, Poulain D. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol. 1996 Mar; 3(2):219-26.
      View in: PubMed
    341. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, Thomas G. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature. 1996 Feb 29; 379(6568):821-3.
      View in: PubMed
    342. Colombel JF, Yazdanpanah Y, Laurent F, Houcke P, Delas N, Marquis P. [Quality of life in chronic inflammatory bowel diseases. Validation of a questionnaire and first French data]. Gastroenterol Clin Biol. 1996; 20(12):1071-7.
      View in: PubMed
    343. Colombel JF, Hugot JP. [Genetics of Crohn disease: a complex model]. Gastroenterol Clin Biol. 1996; 20(5 Pt 2):B15-20.
      View in: PubMed
    344. Gower-Rousseau C, Grandbastien B, Cortot A, Colombel JF. Epidemiology of inflammatory bowel disease: is there a "Belgian-French exception?". Acta Gastroenterol Belg. 1996 Jan-Mar; 59(1):2.
      View in: PubMed
    345. Buisine MP, Janin A, Maunoury V, Audié JP, Delescaut MP, Copin MC, Colombel JF, Degand P, Aubert JP, Porchet N. Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. Gastroenterology. 1996 Jan; 110(1):84-91.
      View in: PubMed
    346. Wallaert B, Desreumaux P, Copin MC, Tillie I, Benard A, Colombel JF, Gosselin B, Tonnel AB, Janin A. Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. J Exp Med. 1995 Dec 1; 182(6):1897-904.
      View in: PubMed
    347. Carrette O, Favier C, Mizon C, Neut C, Cortot A, Colombel JF, Mizon J. Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's disease. Dig Dis Sci. 1995 Dec; 40(12):2641-6.
      View in: PubMed
    348. Boruchowicz A, Desreumaux P, Maunoury V, Colombel JF. Dysphagia revealing esophageal and gastric metastases of renal carcinoma. Am J Gastroenterol. 1995 Dec; 90(12):2263-4.
      View in: PubMed
    349. Reumaux D, Mézière C, Colombel JF, Duthilleul P, Mueller S. Distinct production of autoantibodies to nuclear components in ulcerative colitis and in Crohn's disease. Clin Immunol Immunopathol. 1995 Dec; 77(3):349-57.
      View in: PubMed
    350. Sahmoud T, Hoctin-Boes G, Modigliani R, Bitoun A, Colombel JF, Soule JC, Florent C, Gendre JP, Lerebours E, Sylvester R. Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gut. 1995 Dec; 37(6):811-8.
      View in: PubMed
    351. Klein O, Colombel JF, Lescut D, Gambiez L, Desreumaux P, Quandalle P, Cortot A. Remaining small bowel endoscopic lesions at surgery have no influence on early anastomotic recurrences in Crohn's disease. Am J Gastroenterol. 1995 Nov; 90(11):1949-52.
      View in: PubMed
    352. Aldebert D, Notteghem B, Reumaux D, Lassalle P, Lion G, Desreumaux P, Duthilleul P, Colombel JF. Anti-endothelial cell antibodies in sera from patients with inflammatory bowel disease. Gastroenterol Clin Biol. 1995 Nov; 19(11):867-70.
      View in: PubMed
    353. Zenjari T, Boruchowicz A, Desreumaux P, Laberenne E, Cortot A, Colombel JF. Association of coeliac disease and portal venous thrombosis. Gastroenterol Clin Biol. 1995 Nov; 19(11):953-4.
      View in: PubMed
    354. Neut C, Guillemot F, Gower-Rousseau C, Biron N, Cortot A, Colombel JF. [Treatment of diversion colitis with short-chain fatty acids. Bacteriological study]. Gastroenterol Clin Biol. 1995 Nov; 19(11):871-5.
      View in: PubMed
    355. Baron P, Lucidarme D, Boruchowicz A, Lecomte-Houcke M, Quandalle P, Colombel JF. [Lymphomas of the colon complicating hemorrhagic rectocolitis]. Gastroenterol Clin Biol. 1995 Nov; 19(11):935-9.
      View in: PubMed
    356. Dubucquoi S, Janin A, Klein O, Desreumaux P, Quandalle P, Cortot A, Capron M, Colombel JF. Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut. 1995 Aug; 37(2):242-6.
      View in: PubMed
    357. Talbodec N, Bottelin E, Boruchowicz A, Merlier O, Paris JC, Colombel JF. Splenic abscess associated with Pasteurella multocida in an immunocompetent patient. J Clin Gastroenterol. 1995 Jul; 21(1):76.
      View in: PubMed
    358. Desreumaux P, Janin A, Delaporte E, Dubucquoi S, Piette F, Cortot A, Capron M, Colombel JF. Parallel interleukin 5 synthesis by eosinophils in duodenal and skin lesions of a patient with dermatitis herpetiformis. Gut. 1995 Jul; 37(1):132-5.
      View in: PubMed
    359. Boruchowicz A, Wallaert B, Cortot A, Bouault JM, Paris JC, Colombel JF. Idiopathic acute pancreatitis and sarcoidosis. Gastroenterol Clin Biol. 1995 Apr; 19(4):439-41.
      View in: PubMed
    360. Gosset P, Wallaert B, Canva-Delcambre V, Colombel JF, Tonnel AB. Impaired secretion and mRNA expression of monokines by alveolar macrophages from nonsmoking patients with alcoholic liver cirrhosis. J Infect Dis. 1995 Mar; 171(3):743-6.
      View in: PubMed
    361. Prigent-Delecourt L, Coffin B, Colombel JF, Dehennin JP, Vaerman JP, Rambaud JC. Secretion of immunoglobulins and plasma proteins from the colonic mucosa: an in vivo study in man. Clin Exp Immunol. 1995 Feb; 99(2):221-5.
      View in: PubMed
    362. Gower-Rousseau C, Salomez JL, Dupas JL, Marti R, Nuttens MC, Votte A, Lemahieu M, Lemaire B, Colombel JF, Cortot A. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut. 1994 Oct; 35(10):1433-8.
      View in: PubMed
    363. Comes MC, Gower-Rousseau C, Colombel JF, Belaïche J, Van Kruiningen HJ, Nuttens MC, Cortot A. Inflammatory bowel disease in married couples: 10 cases in Nord Pas de Calais region of France and Liège county of Belgium. Gut. 1994 Sep; 35(9):1316-8.
      View in: PubMed
    364. Colombel JF, Gower-Rousseau C, Laurent-Puig P. [Inflammatory bowel diseases: genetic hypothesis]. Acta Gastroenterol Belg. 1994 Sep-Dec; 57(5-6):285-91.
      View in: PubMed
    365. Flipo RM, Cotten A, Derisquebourg T, Colombel JF, Duquesnoy B, Delcambre B. [Hip diseases in hemorrhagic rectocolitis. Apropos of 4 cases]. Rev Rhum Ed Fr. 1994 Feb; 61(2):139-42.
      View in: PubMed
    366. Boruchowicz A, Wallaert B, Vandermolen P, Colombel JF. [Sarcoidosis and the digestive tract]. Gastroenterol Clin Biol. 1994; 18(12):1119-28.
      View in: PubMed
    367. Gower-Rousseau C, Reumaux D, Bellard M, Delecourt L, Ribet M, Colombel JF. Remission of myasthenia gravis after proctocolectomy in a patient with ulcerative colitis. Am J Gastroenterol. 1993 Jul; 88(7):1136-8.
      View in: PubMed
    368. Lescut D, Vanco D, Bonnière P, Lecomte-Houcke M, Quandalle P, Wurtz A, Colombel JF, Delmotte JS, Paris JC, Cortot A. Perioperative endoscopy of the whole small bowel in Crohn's disease. Gut. 1993 May; 34(5):647-9.
      View in: PubMed
    369. Reumaux D, Colombel JF, Delecourt L, Noël LH, Cortot A, Duthilleul P. Anti-neutrophil cytoplasmic auto-antibodies (ANCA) in patients with ulcerative colitis (UC): influence of disease activity and familial study. Adv Exp Med Biol. 1993; 336:515-8.
      View in: PubMed
    370. Reumaux D, Colombel JF, Duclos B, Chaussade S, Belaïche J, Jacquot S, Dupas JL, Molis C, Duthilleul P. Antineutrophil cytoplasmic auto-antibodies in sera from patients with ulcerative colitis after proctocolectomy with ileo-anal anastomosis. Adv Exp Med Biol. 1993; 336:523-5.
      View in: PubMed
    371. Notteghem B, Salomez JL, Gower-Rousseau C, Marti R, Lemahieu M, Nuttens MC, Dupas JL, Colombel JF, Cortot A. [What is the prognosis in unclassified colitis? Results of a cohort study of 104 patients in the Northern-Pas-de-Calais region]. Gastroenterol Clin Biol. 1993; 17(11):811-5.
      View in: PubMed
    372. Lucidarme D, Colombel JF, Brandtzaeg P, Tulliez M, Chaussade S, Marteau P, Dehennin JP, Vaerman JP, Rambaud JC. Alpha-chain disease: analysis of alpha-chain protein and secretory component in jejunal fluid. Gastroenterology. 1993 Jan; 104(1):278-85.
      View in: PubMed
    373. Reumaux D, Delecourt L, Colombel JF, Noël LH, Duthilleul P, Cortot A. Anti-neutrophil cytoplasmic autoantibodies in relatives of patients with ulcerative colitis. Gastroenterology. 1992 Nov; 103(5):1706.
      View in: PubMed
    374. el Yamani J, Mizon C, Capon C, Colombel JF, Fournet B, Cortot A, Mizon J. Decreased faecal exoglycosidase activities identify a subset of patients with active Crohn's disease. Clin Sci (Lond). 1992 Oct; 83(4):409-15.
      View in: PubMed
    375. Colombel JF, Torpier G, Janin A, Klein O, Cortot A, Capron M. Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein. Gut. 1992 Sep; 33(9):1190-4.
      View in: PubMed
    376. el Yamani J, Soudan B, Mizon C, Colombel JF, Balduyck M, Cortot A, Mizon J. A simple method for the measurement of different forms of alpha 1 proteinase inhibitor in the faeces of patients with Crohn's disease. Ann Clin Biochem. 1992 Jul; 29 ( Pt 4):418-21.
      View in: PubMed
    377. Wallaert B, Colombel JF, Adenis A, Marchandise X, Hallgren R, Janin A, Tonnel AB. Increased intestinal permeability in active pulmonary sarcoidosis. Am Rev Respir Dis. 1992 Jun; 145(6):1440-5.
      View in: PubMed
    378. Wallaert B, Colombel JF, Prin L, Sibille Y, Tonnel AB. Bronchoalveolar lavage in alcoholic liver cirrhosis. T-lymphocyte subsets and immunoglobulin concentrations. Chest. 1992 Feb; 101(2):468-73.
      View in: PubMed
    379. Villey MC, Ehrsam E, Marrakchi S, Colombel JF, Thomas P. Apudoma and subcorneal pustular dermatosis (Sneddon-Wilkinson disease). Dermatology. 1992; 185(4):269-71.
      View in: PubMed
    380. Piette F, Colombel JF, Delaporte E. [Skin manifestations of inflammatory diseases of the gastrointestinal tract]. Ann Dermatol Venereol. 1992; 119(4):297-306.
      View in: PubMed
    381. Laffineur G, Lescut D, Vincent P, Quandalle P, Wurtz A, Colombel JF. [Bacterial translocation in Crohn disease]. Gastroenterol Clin Biol. 1992; 16(10):777-81.
      View in: PubMed
    382. Desreumaux P, Janin A, Colombel JF, Prin L, Plumas J, Emilie D, Torpier G, Capron A, Capron M. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med. 1992 Jan 1; 175(1):293-6.
      View in: PubMed
    383. Colombel JF, Reumaux D, Duthilleul P, Noël LH, Gower-Rousseau C, Paris JC, Cortot A. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases. Gastroenterol Clin Biol. 1992; 16(8-9):656-60.
      View in: PubMed
    384. Guillemot F, Colombel JF, Neut C, Verplanck N, Lecomte M, Romond C, Paris JC, Cortot A. Treatment of diversion colitis by short-chain fatty acids. Prospective and double-blind study. Dis Colon Rectum. 1991 Oct; 34(10):861-4.
      View in: PubMed
    385. Wallaert B, Aerts C, Colombel JF, Voisin C. Human alveolar macrophage antibacterial activity in the alcoholic lung. Am Rev Respir Dis. 1991 Aug; 144(2):278-83.
      View in: PubMed
    386. Mesnard B, Desreumaux P, Colombel JF. [Digestive manifestations of food hypersensitivity in adults]. Rev Med Interne. 1991 Jul-Aug; 12(4):289-94.
      View in: PubMed
    387. Mizon C, el Yamani J, Colombel JF, Maes P, Balduyck M, Laine A, Cortot A, Tartar A, Mizon J. Deglycosylation of alpha 1-proteinase inhibitor is impaired in the faeces of patients with active inflammatory bowel disease (Crohn's disease). Clin Sci (Lond). 1991 May; 80(5):517-23.
      View in: PubMed
    388. Colombel JF, Vaerman JP, Mesnard B, Dehennin JP, Dive C, Rambaud JC. Jejunal immunoglobulin secretion in alcoholic patients with and without cirrhosis. J Hepatol. 1991 Mar; 12(2):145-9.
      View in: PubMed
    389. Cortot A, Gower-Rousseau C, Colombel JF. [Epidemiology and genetics of inflammatory bowel diseases]. Rev Prat. 1991 Feb 11; 41(5):393-6.
      View in: PubMed
    390. Colombel JF, Mizon C, Chekkouri N, Balduyck M, Chaussade S, Becuwe C, Degand P, Mizon J, Cortot A. [Qualitative study of fecal alpha-1-antitrypsin in patients with inflammatory digestive disease and patients with ileostomy]. Gastroenterol Clin Biol. 1991; 15(4):301-5.
      View in: PubMed
    391. Gottrand F, Colombel JF, Moreno L, Salomez JL, Farriaux JP, Cortot A. [Incidence of inflammatory bowel diseases in children in the Nord-Pas-de-Calais region]. Arch Fr Pediatr. 1991 Jan; 48(1):25-8.
      View in: PubMed
    392. Colombel JF, Mascart-Lemone F, Nemeth J, Vaerman JP, Dive C, Rambaud JC. Jejunal immunoglobulin and antigliadin antibody secretion in adult coeliac disease. Gut. 1990 Dec; 31(12):1345-9.
      View in: PubMed
    393. Servais B, Colombel JF, Louis E, Belaiche J. [Digestive immune system and neuroendocrine peptides]. Rev Med Liege. 1990 Jul; 45(7):335-42.
      View in: PubMed
    394. Huet G, Balduyck M, Mizon C, Colombel JF, Mizon J. Fecal alpha 1-antichymotrypsin in inflammatory bowel diseases. Clin Chem. 1990 Mar; 36(3):576.
      View in: PubMed
    395. Colombel JF. [Interactions between gastrointestinal epithelial cells and immune system cells]. Gastroenterol Clin Biol. 1990; 14(12 ( Pt 2)):41D-43D.
      View in: PubMed
    396. Bonnière P, Henry-Amar M, Lescut D, Mathieu-Chandelier C, Colombel JF, Delhoustal L, Chastanet P, Ancelin JP, Delette O, Cortot A, et al. [Transhepatic embolization and endoscopic sclerosing in digestive hemorrhage caused by rupture of esophageal varices in patients with Child's stage C cirrhosis]. Gastroenterol Clin Biol. 1990; 14(1 ( Pt 2)):46B-51B.
      View in: PubMed
    397. Lescut D, Colombel JF, Vincent P, Cortot A, Fournier L, Quandalle P, Vankemmel M, Triboulet JP, Wurtz A, Paris JC, et al. Bacterial translocation in colorectal cancers. Gastroenterol Clin Biol. 1990; 14(11):811-4.
      View in: PubMed
    398. Mathieu-Chandelier C, Torpier G, Colombel JF, Capron M. [Eosinophils and pathology of the digestive tract]. Gastroenterol Clin Biol. 1990; 14(11):824-31.
      View in: PubMed
    399. Colombel JF, Dupas JL, Cortot A, Salomez JL, Marti R, Gower-Rousseau C, Capron-Chivrac D, Lerebours E, Czernichow B, Paris JC. [Incidence of inflammatory bowel disease in the Nord-Pas-de-Calais region and the Somme area of France in 1988]. Gastroenterol Clin Biol. 1990; 14(8-9):614-8.
      View in: PubMed
    400. Farre JM, Perez T, Hautefeuille P, Tonnel F, Colombel JF, Duquesnoy B, Delcambre B. Cholestasis and pneumonitis induced by gold therapy. Clin Rheumatol. 1989 Dec; 8(4):538-40.
      View in: PubMed
    401. Neut C, Colombel JF, Guillemot F, Cortot A, Gower P, Quandalle P, Ribet M, Romond C, Paris JC. Impaired bacterial flora in human excluded colon. Gut. 1989 Aug; 30(8):1094-8.
      View in: PubMed
    402. Colombel JF, Guillemot F, Van Gossum A, Dufossé F, Cortot A, Dupont E, Paris JC. Familial Crohn's disease in multiple siblings: no linkage to the HLA system. Gastroenterol Clin Biol. 1989 Aug-Sep; 13(8-9):676-8.
      View in: PubMed
    403. Hällgren R, Colombel JF, Dahl R, Fredens K, Kruse A, Jacobsen NO, Venge P, Rambaud JC. Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents. Am J Med. 1989 Jan; 86(1):56-64.
      View in: PubMed
    404. Becuwe C, Delaporte E, Colombel JF, Piette F, Cortot A, Bergoend H. Sweet's syndrome associated with Crohn's disease. Acta Derm Venereol. 1989; 69(5):444-5.
      View in: PubMed
    405. Colombel JF, Salomez JL, Cortot A, Marti R, Lemaire B, Beuscart R, Dupas JL, Czernichow P, Colin R, Paris JC. Incidence of inflammatory bowel disease in northwestern France. Preliminary results in region Nord-Pas-de-Calais. Scand J Gastroenterol Suppl. 1989; 170:22-4; discussion 50-5.
      View in: PubMed
    406. Colombel JF, Hällgren R, Engström-Laurent A, Rambaud JC. Hyaluronic acid and type III procollagen peptide in jejunal perfusion fluid as markers of connective tissue turnover. Gastroenterology. 1989 Jan; 96(1):68-73.
      View in: PubMed
    407. Torpier G, Colombel JF, Mathieu-Chandelier C, Capron M, Dessaint JP, Cortot A, Paris JC, Capron A. Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein. Clin Exp Immunol. 1988 Dec; 74(3):404-8.
      View in: PubMed
    408. Degott C, Messing B, Moreau D, Chazouillères O, Paris R, Colombel JF, Lebrec D, Potet F, Feldmann G, Benhamou JP. Liver phospholipidosis induced by parenteral nutrition: histologic, histochemical, and ultrastructural investigations. Gastroenterology. 1988 Jul; 95(1):183-91.
      View in: PubMed
    409. Lescut D, Colombel JF, Parent M, Bonnière P, Guillemot F, Cortot A, Paris JC. [An enigmatic occlusive syndrome]. Ann Gastroenterol Hepatol (Paris). 1988 May-Jun; 24(3):115-6.
      View in: PubMed
    410. Colombel JF, Parent M, Lescut D, Cortot A, Guillemot F, Plane C, Bonnière P, Lecomte-Houcke M, Paris JC. Paraneoplastic intestinal pseudo-obstruction as the presenting feature of small-cell lung cancer. Gastroenterol Clin Biol. 1988 Apr; 12(4):394-6.
      View in: PubMed
    411. Colombel JF, Flourie B, Neut C, Florent C, Leblond A, Rambaud JC. [Methanogenesis in man]. Gastroenterol Clin Biol. 1987 Oct; 11(10):694-700.
      View in: PubMed
    Colombel's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067